Development and clinical application of first trimester chorionic villus sampling for fetal diagnosis by Mackenzie, William Ewen
THE DEVELOPMENT AND CLINICAL APPLICATION
OF FIRST TRIMESTER CHORIONIC VILLUS SAMPLING
FOR FETAL DIAGNOSIS
by
William Ewen MacKenzie, B.Sc., MB.ChB., M.R.C.O.G.
Submitted for the Degree of Doctor of Medicine in the
Faculty of Medicine of the University of Edinburgh
June 1988
AIMS OF THE THESIS
1. To critically review methods of prenatal diagnosis
with special reference to chorionic villus sampling
(Chapters 1-3).
2. To design suitable cannulae for transcervical chorionic
villus sampling which fulfil certain specified criteria
(Chapter 4.3).
3. To compare such cannulae with a widely used cannula in a
randomised study examining factors influencing villus
recovery and subsequent karyotyping (Chapters 4.5,4.6).
4. To investigate a method of transabdominal chorionic villus
sampling and, in particular, the effect of placental site
on villus recovery and comparing transabdominal with
transcervical chorionic villus sampling methods (Chapters
5-6) .
5. To assess methods of chromosomal analysis from chorionic
villi using a direct method of karyotype preparation and
comparing it to short term culture methods (Chapter 7).
6. To present a diagnostic series of patients in whom the
methods of chorionic villus sampling developed were used
for fetal diagnosis (Chapter 8).
7. To obtain previously unknown data on the spontaneous
abortion rate in a cohort of first trimester pregnancies
demonstrated to be viable by ultrasound examination and
prospectively followed until at least 28 weeks gestation
(Chapter 9).
ABSTRACT
THE DEVELOPMENT AND CLINICAL APPLICATION OF FIRST
TRIMESTER CHORIONIC VILLUS SAMPLING FOR FETAL DIAGNOSIS
Two metal cannulae for transcervical chorionic villus
sampling using a suction aspiration method were designed. In
a randomised trial involving 200 transcervical villus samples
taken with the two metal and one plastic cannula, the
aluminium cannula performed best in terms of karyotype
recovery and ease of insertion but placental site influenced
the ability to recover villi for all cannulae.
A method of transabdominal chorionic villus sampling was
adapted to existing equipment. It was compared to an improved
method of transcervical chorionic villus sampling using the
aluminium cannula, in fifty patients. The two methods were
equally successful in obtaining villi but the transcervical
method was significantly better at obtaining villi greater
than 10 milligrams in weight. Placental position did not
affect villus recovery with either sampling method.
Chorionic villi from twenty patients were prepared for
karyotype analysis by a direct and short term culture method
and no significant difference was found in the quality and
quantity of metaphases obtained using either method. A
further study involving twenty patients showed a variable
response of any one villus sample to the methods suggesting
an advantage to processing villi by more than one method.
One hundred patients had fetal diagnosis using the
clinical and laboratory methods that were developed. Fetal
diagnosis was possible in 97% of patients. The overall
spontaneous abortion rate was 5.7%. In a prospective study
of 500 patients who had ultrasound evidence of a viable fetus
below 12 weeks gestation, the spontaneous abortion rate was
2% overall.
In those women with a history of spontaneous abortion,
the abortion rate increased tenfold. Spontaneous abortion
at less than ten weeks was three times higher than that at
greater than ten weeks gestation and this may have implications
for the timing of first trimester chorionic villus sampling.
This work is dedicated to my wife Marilyn and our family.
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REVIEW OF FETAL ABNORMALITY
1.1 INTRODUCTION
A quarter of all perinatal deaths are due to congenital
abnormalities according to the findings of the Scottish
Perinatal Mortality Survey (Mcllwaine ej: a_l 1979). In the
past 50 years, the perinatal mortality rate has declined
steadily as deaths from prematurity, birth asphyxia and
infection have decreased (Nevin 1982). This fall has not
been matched by a fall in the number of deaths from congenital
abnormality and the proportion of perinatal deaths attributable
to congenital abnormalities has risen in comparison to those
from other causes (Nevin 1982).
Congenital abnormalities are present in 5% of liveborn
children (Ferguson-Smith et aJL_ 1984). Data on admissions to
paediatric hospitals in the United States of America has
shown that from 21 - 27% are accounted for by congenital
diseases or conditions with a genetic tendency (Day et a_l
1973; Hall et a_l 1978). Studies in the United Kingdom have
shown that by age seven, 5% of all children suffer from some
kind of impairment, and of these handicaps, 83% are congenital
in origin (Wells 1978).
While there has been increasing understanding of the
underlying causes of certain congenital disorders, coupled
with advances in the clinical, cytogenetic, biochemical and
molecular diagnostic techniques, only a limited number of
congenital disorders can be treated. Prevention of congenital
abnormality is possible through pre-pregnancy counselling in
parents who suffer from conditions known to be associated
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with a risk of fetal abnormality, but in many cases this will
mean voluntary infertility or, in some cases, artifical
insemination with donor semen for certain sex-linked disorders.
Voluntary infertility has, for many couples, been the only
choice when faced with the chance of bearing children with
congenital abnormalities.
In the past twenty years, fetal diagnosis has offered
parents the chance of selective abortion of an abnormal fetus
and in fetal screening programmes, this has led to a 3 to 5%
abortion rate in those screened (Galjaard 1980). For the
majority, however, fetal diagnosis has been performed for
reassurance of the presence of fetal normality and there is
evidence that women at risk of having an abnormal fetus, who
would previously have avoided conception, are now contemplating
pregnancy because they know that screening for fetal
abnormality can be offered and uncertainty about fetal
normality removed (Weatherall 1985).
1.2 INCIDENCE OF MAJOR CONGENITAL DISORDERS
Recent endocrinological studies have demonstrated that
approximately 50% of all conceptions fail (Miller et ad 1980) .
Such failures may not be clinically obvious as a miscarriage
and therefore are classed as a late period. Clinically
apparent abortions occur in about 14% of pregnancies (Royal
College of General Practitioners 1976). Chromosomal studies
on abortus material demonstrates that the incidence of
chromosomal anomalies decreases with the duration of pregnancy.
In one large study of over 1,000 abortions, 49% were
chromosomally abnormal at 8 to 11 weeks gestational age,
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39% from 12 to 15 weeks, 18% from 16 to 19 weeks and 11%
over 20 weeks (Warburton et ad 1980) .
Chromosomal aberrations were present in 9.5% of macerated
stillbirths and 3.5% of non-macerated stillbirths. 5.1% of
liveborn perinatal deaths had chromosomally abnormalities
(Angell et ad 1984) .
External and environmental factors, such as teratogenic
drugs, irradiation and transplacental bacterial and viral
infections, account for 10% of congenital abnormalities
(Kalter et ad 1983) .
The remaining abnormalities can be divided into three
major categories of congenital disorder
A) Congenital malformations
B) Chromosomal aberrations
C) Mendelian (monogenic) disorders
A) Congenital Malformations
These constitute the greatest proportion of congenital
abnormalities. Most are of unknown cause. Those, such as
congenital heart defects, neural tube defects and oro-facial
clefts may be caused by an interaction of genetic and external
factors, as yet of unknown origin. The incidence of certain
of these malformations, for example, neural tube defects, is
affected by geographical and ethnic factors, the incidence
rising from 1 to 2 per thousand in England to 4 to 8 per
thousand in South Wales and Northern Ireland. It appears to




Data from the European Collaborative Study on the
incidence of chromosomal aberrations, which was based on
amniocentesis studies shows that numerical chromosomal
aberrations such as Trisomies 21, 18, 13 and 47,XXY, increase
with maternal age. Whereas the overall incidence of Trisomy
is 2 per thousand newborns in women 24 years of age or less,
it is 8 per thousand in the age group 35 to 39 years and up
to 100 per thousand in women 45 years of age or older
(Ferguson-Smith et 1984) . Certain other chromosomal
aberrations do not show this maternal age effect e.g. 45,XO
Turners Syndrome. The rates of chromosomal aberrations by
maternal age groups are higher than liveborn rates, because
a certain number of chromosomally abnormal fetuses abort
between the gestational age at which amniocentesis would be
performed and delivery. For example, the liveborn rate for
Trisomy 21 is 30% less than the rate found in amniocentesis
patients. The liveborn rate for Trisomy 18 is 68% less than
the amniocentesis rate (Ferguson-Smith et a_l 1984).
In younger women, sporadic chromosomal disorders are
associated with a recurrence risk of 1 to 2% (Mikkleson et al_
1979) .
Most chromosomal aberrations are sporadic non-disjunctions
and rearrangements that occur during formation of the gamete.
Fetal chromosomal aberrations are commoner where one parent
has a balanced chromosomal rearrangement. This rearrangement
is usually detected after chromosomal studies on those
parents having repeated abortions, perinatal deaths or
liveborn, with a chromosomally abnormal fetus. This can lead
in some cases to a high risk of fetal abnormality e.g. in the
case of certain Robertsonian translocations in the mother,
15% of offspring will have Trisomy 21.
C) Mendelian Disorders
McKusick (1983) lists 3,500 different disorders of
Mendelian inheritance. Of these, 1,637 have proven mutant
genotypes, of which 934 are classified as autosomal dominant
(57%), 588 as autosomal recessives (36%) and 115 as
X-1inked (7%).
The overall incidence of these monogenic disorders is
probably 0.5 to 1.4% of liveborn births. Accurate
estimations are difficult because of the complex techniques
needed to be sure of the diagnosis of any one disorder and
the variation in incidence of certain disorders among
different ethnic groups (Galjaard 1980). Cystic fibrosis,
for example, occurs in Caucasians in 1 in 2,500 births but
has been estimated to be rare in Mongolian Chinese, at a rate
of 1 in 90,000.
The prevention of congenital disorders without resorting
to selective abortion is possible for a small number of
conditions. Avoidance of environmental factors associated
with congenital abnormalities such as mutagenic or
teratogenic agents is possible. There is some, though not
conclusive, evidence that periconceptional ingestion of
multivitamins can reduce the incidence of neural tube defects
as well as decrease the recurrence rate (Seller et a_l_ 1984 ;
Smithells et al 1980).
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For the chromosomal aberrations, apart from avoiding
pregnancy within certain maternal age groups, no prevention
short of fetal screening is possible. For the monogenic
disorders, primary prevention is not possible, but if the
facility for carrier detection existed for such disorders
and was applied to large populations coupled with genetic
counselling prior to reproduction, a major impact on the
incidence of these conditions would happen.
1.3 THE IMPACT OF FETAL DIAGNOSIS ON THE BIRTH INCIDENCE
OF CONGENITAL ABNORMALITIES
In the United States of America in 1970, there were
fifty children with Tay Sachs disease born to Ashkenazy
Jews. By 1982, with the widespread uptake of fetal diagnosis,
there were nine new liveborn cases in this ethnic group
(Kaback 1983).
With similar uptake of antenatal diagnosis within a high
risk group e.g. homozygous beta-thalassaemia in Sardinia, the
liveborn incidence of the condition fell three fold between
1977 and 1980 (Cao et al_ 1981).
For the more widespread chromosomal aberrations, the
impact of fetal diagnostic technigues has not been so
dramatic, reflecting the poorer uptake of antenatal diagnosis
within the population. In theory, screening women over 35
years of age by amniocentesis for fetal Trisomy 21 could
reduce the birth incidence of this defect by 35%, the actual
figure in e.g. the Greater Glasgow Health Board area has been
6.5% in 1982, as only 28% of those at risk take up the offer
of amniocentesis (Ferguson-Smith 1983). The amniocentesis
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rate in women of 35 and over varies from 30% in 1984 in the
West Midlands Health Authority area in England (Birmingham
Maternity Hospital Annual Report 1984), to 85% in Denmark
(Evans 1983). Such variation reflects not only public
awareness that such a technique and service is available,
but also the willingness of the medical profession to refer
women for amniocentesis. When mass screening for a
congenital abnormality is offered and accepted, the impact
can be considerable. The birth incidence of neural tube
defects fell by 72% in 1981 in the Greater Glasgow Health
Board area with serum alphafetoprotein screening combined
with subsequent ultrasound and amniocentesis confirmatory
diagnosis (Ferguson-Smith 1983). This fall has occurred in
other areas as well e.g. Mid Glamorgan in Wales had a fall
in birth incidence of spina bifida of 8.4 per thousand births
to 4.0 per thousand using serum alphafetoprotein screening
(Laurence 1983).
Fetal diagnosis need not always be equated with abortion.
Effective pre pregnancy prevention may occur for certain
abnormalities, as has occurred for neural tube defects. Fetal
therapy has a small place in antenatal care at present, but
may expand in the future as the basis of the genetic defect
in certain abnormalities begins to be understood.
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FETAL DIAGNOSTIC TECHNIQUES (EXCLUDING CHORIONIC VILLUS
SAMPLING)
2.1 INTRODUCTION
For the past thirty years, the possibility of fetal
diagnosis has been realised and expanded to become an
accepted and essential part of obstetric practice. Since
the first reported amniocentesis in 1956 (Bevis 1956) in
pregnancies affected by Rhesus isoimmunisation, the scope
and range of fetal diagnostic techniques and indications has
grown. Indeed, it was the availability of liquor from Rhesus
affected pregnancies that gave Steele and Berg in 1966 the
opportunity to develop fetal chromosomal analysis from human
amniotic fluid (Steele et ad 1966) . From then on, the number
of amniocenteses grew steadily until in 1983, it was estimated
that between 70,000 and 140,000 amniocenteses were performed
worldwide (Kaback 1983).
During this time, developments in ultrasound technology
and imaging allowed invasive techniques such as amniocentesis
and fetoscopy to become easier. As the image quality and
precision of ultrasound improved, especially the development
of real time grey scale ultrasonography, so the range of
fetal abnormalities that could be diagnosed increased.
Certain procedures like fetoscopy and direct needle
puncture of fetal vessels (cordocentesis) were concentrated
in particular referral centres, so that the personnel
involved became adept at them and consequently maternal and
fetal complications were reduced. While it was recognised
in the late 1960's that techniques should be developed that
would permit very early fetal diagnosis (Warburton et a_l 1972) ,
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it was not until reports appeared in 1982 of the successful
use of chorionic villi obtained in the first trimester for
the fetal diagnosis of haemoglobinopathies (Old et a_l 1982)
and rapid fetal karyotype determination (Simoni et ad 1983),
that interest in using this tissue for first trimester fetal
diagnosis was aroused.
The current methods used in fetal diagnosis are
Amniocentesis, Ultrasound, Fetoscopy, Cordocentesis and
Chorionic Villus Sampling.
2.2 AMNIOCENTESIS
Amniotic fluid and amniotic fluid cells obtained by
transabdominal needle puncture can be used for the fetal
diagnosis of chromosomal aberrations, fetal sexing, inborn
errors of metabolism and neural tube defects.
Laboratory studies have shown that the lower limit of
reliable amniotic fluid sampling for cytogenetic tests is
16 weeks gestation (Gosden 1983). Good tissue cultures can
be obtained from 10 mis of amniotic fluid. Results usually
take three weeks to obtain, although with hormone enriched
media, the time can be reduced to 10 to 12 days. In many
cases therefore, a diagnosis of fetal abnormality will not
be obtained until 18 weeks gestation at the earliest.
There have been several large studies on the safety of
amniocentesis. A study from the United States of America
had found no difference in fetal loss rates between cases
and controls, but there may have been bias in the selection
of the controls (N.I.C.H.D. 1976). A Canadian study
demonstrated that the fetal loss rate between controls and
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those having an amniocentesis was the same (Medical Research
Council of Canada Report 1977). In contrast, a British study
(Medical Research Council Report 1978) found a 1.3% increased
spontaneous abortion rate in the amniocentesis group compared
with controls. In a randomised study from Denmark, which
examined women at low risk of fetal abnormality, the excess
abortion rate in the amniocentesis group was 1% (Tabor et a_l
1986). This report also found an increased rate of transient
respiratory difficulty in babies from the amniocentesis group
compared with controls as had also been noted in the British
study (Medical Research Council Report 1978). The Danish
study did not however confirm the increased risk of
orthopaedic abnormalities found in the British study. Factors
affecting the risk of abortion in Tabor's study included
transplacental amniocentesis, but there was no increase in
intrauterine growth retardation or prematurity.
One factor not mentioned in the Danish study was the
influence of the needle size used for the amniocentesis, as
a factor in causing spontaneous abortion. Whereas they had
reported that an 18 gauge needle was used for all
amniocenteses, the usual practice in the United Kingdom was
for a smaller 21 or 22 gauge needle. Data from two surveys
(N.I.C.H.D. 1976; Medical Research Council of Canada Report
1977) supported the view that the use of needles larger than
19 gauge was associated with an increased abortion rate.
Perhaps the use of the larger needle in the Danish group's
study led to a greater abortion rate than would have occurred
had a smaller needle been used.
This caveat aside, the Danish randomised study allowed
a prediction of miscarriage from amniocentesis to be reliably
quoted, thus ending the uncertainty caused previously by
biased studies.
2.3 ULTRASOUND
With the advent of real time high resolution ultrasound
equipment, requiring few operating manoeuvres to obtain good
quality ultrasound images, the number of ultrasound procedures
performed on pregnant women has markedly increased. A Royal
College of Obstetricians and Gynaecologists Working Party on
Routine Ultrasound in Pregnancy (Royal College of Obstetricians
and Gynaecologists Report 1984) estimated that during 1983
up to 75% of all pregnant women in England had ultrasonography
performed compared with less than 10% in 1972. Rates in
Scotland were similar and in Northern Ireland nearly 100% of
all pregnant women had ultrasonography in 1983.
Early reports on the diagnosis of fetal abnormality by
ultrasound concentrated on the diagnosis of anencephaly and
spina bifida. In a centre specifically performing a fetal
anomaly scanning service, 211 cranio spinal defects were
detected, out of a population of 1,473 referred because of
high risk (Campbell 1984).
The sensitivity of ultrasound in detecting neural tube
defects improved from 33% to 80% in another report from a
non-specialised centre in a 10 year period (Roberts et ad
1983) .
Such success in a population at high risk for a fetal
disorder, such as spina bifida, is not matched in studies on
the low risk population, when screening for fetal disorders.
Persson et al, in 1983, reporting on their long term
experience of routine ultrasound screening in pregnancy,
detected only 12 of 50 fetal malformations at 17 weeks
gestation. The majority (38 of 50) were detected at 33 weeks
gestation, a stage at which termination of the pregnancy
would not have been possible if desired. Similarly,
Eik-Nes et al, in 1984, reporting on one of the few
randomised studies examining the effectiveness of routine
ultrasound screening,showed no statistical difference in
perinatal mortality or morbidity rates between the routine
and the non-routine scanned groups.
As the frequency of most major structural defects is low,
about 1 in 1,000 births, any one ultrasonographer will spend
many thousands of hours performing detailed scans on many
women in order to pick up one abnormality.
Routine mass screening for fetal abnormality, using
ultrasound in populations at low risk, is likely to be
ineffective as long as the rate limiting factor is machine
quality, and operator experience and concentration.
2 . 4 FETOSCOPY
Fetoscopy is a method of direct fetal visualisation in
which a small 2 mm diameter endoscope is passed trans¬
abdominal ly through the anterior wall of the uterus and into
the amniotic sac. Originally used for the diagnosis of
neural tube defects, its use was extended to umbilical cord
blood sampling and tissue biopsy from the fetus. Its use in
the management of Rhesus isoimmunisation has extended to fetal
therapy by direct intravascular transfusion in severely
affected fetuses. It has been used extensively for the
diagnosis of Haemoglobinopathies and Haemophilia, and in the
rapid karyotyping of fetal blood in non immune Hydrops and
intrauterine growth retardation, when a fetal chromosomal
abnormality is suspected (Nicolaides et aJL_ 1985). Fetoscopy
is associated with a 2 - 5% spontaneous miscarriage rate and
an 8 - 10% incidence of premature labour. Four to five per
cent of women having a fetoscopy will have a persistent leak
of amniotic fluid (Rodeck 1983).
These high complication rates restrict the indications
for the procedure. The usefulness of fetoscopy has now
declined to be replaced by cordocentesis and chorionic villus
sampling.
2.5 CORDOCENTESIS
With the improvement in resolution of ultrasound
equipment, real time visualisation and guidance of needles
into the umbilical cord has become possible. This technique,
named 'Cordocentesis', has largely replaced fetoscopy. Apart
from obtaining fetal blood for use in the diagnosis of
chromosomal, biochemical and blood disorders, its use has
also been extended to fetal therapy, in the case of Rhesus
isoimmunisation (de Crespigny et a^ 1985).
It has also been used in studies of fetal oxygenation
and in acid base studies of the growth retarded fetus
(Soothill et al 1986 a; Soothill et al 1986 b).
In the United Kingdom, its use has largely been
restricted to one or two centres and estimations of fetal
loss from large series of cordocenteses can be as low as
7 out of 562 cases (Daffos et a_l 1985) . The fetal losses,
where the indication is Rhesus isoimmunisation or fetal
hypoxia, may be greater.
CHORIONIC VILLUS SAMPLING
3 . 1 INTRODUCTION
The techniques of amniocentesis, ultrasound, fetoscopy
or cordocentesis can only be used for the prenatal diagnosis
of fetal abnormality in the second trimester of pregnancy.
The earliest gestational age used for amniocentesis for
cytogenetic purposes is 16 weeks. Data from the West Midlands
Amniocentesis Audit 1985 shows a lag time of 10 to 22 days
for the karyotype result leading to an average gestational
age at termination of pregnancy for karyotype abnormality at
19 weeks 2 days (range 17 weeks 5 days to 23 weeks 5 days).
At such gestations, the majority of pregnant women will
have felt fetal movement. Uterine size will be obvious, not
only to the woman herself but also to her family and friends.
If termination of pregnancy is undertaken, because of fetal
abnormality, the physical and emotional complications are
considerable in comparison to first trimester termination of
pregnancy. In two studies, depression and guilt were long
term effects of second trimester termination of pregnancy for
reasons of fetal abnormality (Donnai et a_l 1981; Blumberg
et al 1975).
Midtrimester abortion using prostaglandins as the
abortificient agent has a complication rate of 24 per 100
abortions compared to that of first trimester abortions, in
which the equivalent rate is 6 per 100 abortions (Grimes et aH
1979). In one study, the risks of maternal death rose from
0.6 per 100,000 first trimester abortions to 15.7 per
100,000 abortions carried out between 16 to 20 weeks (Binkin
1986) .
The problems associated with delayed diagnosis and late
termination of pregnancy had been recognised as drawbacks of
amniocentesis and had led to unsuccessful attempts at first
trimester amniocentesis via a vaginal approach (Scrimgeour
1973).
The possibility of using tissue other than amniotic fluid
for earlier prenatal diagnosis was first explored in
Scandinavia in the late 1960's.
3.2 THE EMBRYOLOGICAL DEVELOPMENT OF CHORIONIC VILLI
After fertilisation in the Fallopian tube, the ovum
enters the uterine cavity as a dividing ball of cells (the
morula). After shedding its outer covering (the zona
pellucida) it is termed a blastocyst. The outer layer of
the blastocyst (the trophoblastic cell mass) will form the
outer embryonic membrane (the chorion) and placenta. The
inner layer of the blastocyst will develop into the embryo
itself as well as the amnion and yolk sac. Normally all
cells of the blastocyst are diploid (46 chromosomes) and of
fetal origin.
The chorion is composed of an outer layer of trophoblast
and an inner mesodermal layer containing blood vessels. The
trophoblast cells invade the endometrium and differentiate
into two layers. The inner layer consists of mononuclear
cytotrophoblastic cells with well defined membranes. The
outer layer of syncytiotrophoblast, is formed by fusion of
cytotrophoblastic cells and there are no obvious cell
membranes visible. DNA synthesis and mitotic activity occur
in the nuclei of the cytotrophoblastic cells but not in the
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syncytiotrophoblast. Between days 13 and 14 after
fertilisation, the cytotrophoblast proliferates into the
syncytiotrophoblast to form clumps termed primary chorionic
villi. By the time these acquire connective tissue cover
(day 15), they are termed secondary villi. They eventually
cover the entire surface of the chorion. When capillaries
develop in the connective tissue cores of the villi they are
termed tertiary villi. All three types of villi can be
present at the same time. The cytotrophoblastic extension
from the villi which penetrate the syncytiotrophoblast and
join, form the cytotrophoblastic shell which anchors the
chorionic sac to the maternal endometrium.
Up to eight weeks gestation, the entire chorionic sac
is covered with villi but as the sac grows from the
implantation site, the blood vessels in the decidua
capsularis (the area overlying the conceptus) are compressed
and degenerate, the villi disappear and the region becomes
smooth (termed the chorion laeve at that stage). At around
this time, villi in the decidua basalis (the area underlying
the conceptus) increase and arborise to form a thick layer
termed the chorion frondosum (the fetal component of the
placenta). The decidua basalis forms the maternal component
(decidual plate). As the villi invade the decidua basalis,
they leave decidual tissue wedges called placental septa
which divide the fetal part of the placenta into 10 to 38
cotyledons, each of which contain two or more stem villi.
A single villus examined under a low power microscope
has the appearance noted in figure 1. The outer covering is










FIGURE 1: A SINGLE VILLUS SHOWING 'BUDDING' SPROUTS
AND VASCULAR CORE (x500 )
cytotrophoblastic layer. It is within the inner layer that
mitotic activity occurs and it is these cells that are used
in the direct preparation technique of cytogenetic analysis
(Chapter 7).
The chorion frondosum is 3 to 6 mms thick and can be
identified in the pregnant woman using grey scale ultra¬
sonography. It is the villi of this area that is sampled in
chorionic villus sampling. The chorion mass is about 5 to
80 gms at 8 to 12 weeks gestation (Rushton 1987), and typical
diagnostic samples of 10 to 20 mgs will remove from 0.1 to
0.4% of the total villus mass.
3.3 TRANSCERVICAL CHORIONIC VILLUS SAMPLING TECHNIQUES
A) Endoscopic (Direct Vision) Techniques
In 1968, Mohr in Denmark had proposed taking biopsies
of the chorion of early pregnancies for fetal study using a
transvaginal hysteroscopic approach. Hahnemann and Mohr in
1968, presented the first report on this work and Hahnemann
reviewed all their work from 1968 to 1974, in a report on a
total of 95 cases (Hahnemann 1974).
The sampling instrument consisted of a 6 mm diameter
hysteroscope with a forward visual angle of 60°. Close to
the tip of the instrument was a 4 x 4 mm opening into which
the tissue to be sampled was sucked by the application of a
partial vacuum. A cylindrical knife housed within the
cannula was then advanced and rotated cutting the tissue for
removal. Ninety five women from 8 to 14 weeks gestation
scheduled for termination of pregnancy had such a procedure
attempted. All but 28 had it performed under general
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anaesthetic prior to the termination. A satisfactory biopsy
was obtained in 50 women. In 24 patients, in whom fetal tissue
was obtained after the termination, culture of such tissue
matched the culture of the sample. Of 24 patients, who had
sampling performed without anaesthesia, as out patients, ten
had complications of the procedure 'inconsistent with
continuing pregnancy1. Although Hahnemann concluded that the
procedure was feasible as a method of obtaining tissue
sufficient for prenatal diagnosis in the first trimester, the
hazards of the procedure to the fetus were considerable.
Kullander and Sandahl, in Sweden (1973) also experimented
with chorionic villus sampling using a direct vision approach.
Their device, which they termed an endocervicoscope was 5 mms
in diameter, with forward view incorporating a biopsy
forceps which could grasp the villi and avulse it. They
used this device on 39 patients prior to termination of
pregnancy, some under general anaesthesia and some without
(precise numbers were not given). Successful culture of villi
for chromosomal analysis was possible in 14 of 25 first
trimester patients, and 7 of 14 second trimester patients.
Interestingly, 19 patients had a delay of between 7 and 43
days from sampling to termination and there was no evidence
of a spontaneous abortion in these patients, although precise
ascertainment of fetal viability was not performed, ultra¬
sonography not being routinely available at that time.
These two Scandinavian studies proved that chorionic
villus sampling was possible, that karyotyping of the fetus
could be done from the samples obtained and in the short
follow up of a small number of patients, immediate abortion
did not occur.
These studies did not lead to other published work in
this technique of prenatal diagnosis until 1982.
During the 1970's, the research and applied uses of
amniotic fluid coupled with the relative ease of obtaining it
concentrated efforts into amniocentesis for fetal diagnosis.
In 1982, a report of first trimester chorion biopsy using
an endoscopic technique (and later an ultrasound guided
technique) appeared from the Soviet Union (Kazy et a_l 1982).
In 55 cases prior to termination of pregnancy chorion was
obtained using an endoscopic technique. A 1.7 mm fetoscope
was passed through the cervix into the uterus until the
chorion frondosum was seen. Tissue was removed using biopsy
forceps included with the fetoscopic unit. One hundred and
ten cases had chorion biopsies attempted using a flexible
forceps with an outer diameter of 2 mms, which was inserted
and guided to the chorion by means of continuous real time
ultrasound guidance. Whereas the majority of the 165 cases
reported by this group had villus sampling performed for the
analysis of enzymatic activity, 26 patients at risk of sex
linked conditions had sampling performed for fetal sexing.
Thirteen of these had their pregnancies terminated but 13
continued without incident, and the report contained details
of the delivery weight of 11 patients (2 being undelivered
at the time of the report).
This was the first report of successful chorionic villus
sampling using ultrasound to guide the sampling instrument
and also to give details of the follow up of diagnostic
cases to delivery.
In 1982, another report on direct vision chorionic villus
sampling appeared, in which fetal sexing was the indication
for the procedure. All patients were sampled under general
anaesthetic before termination of pregnancy. A 2.2 mm
fetoscope was used transcervically but a new feature was the
instillation of several millilitres of warmed isotonic
saline to facilitate separation of the decidua capsularis
from the decidua parietalis to aid visualisation of the
chorion (Gosden et aH 1982).
Using a similar fetoscopic system, combined with the
instillation of warmed isotonic saline, Gustavii reported on
100 diagnostic cases (Gustavii 1984 a). His fetoscope was
1.7 mms in diameter with a specially designed channel 3.0
by 4.7 mms in outer diameter containing two attachments,
one for the infusion of the warmed isotonic saline and the
other for the biopsy forceps.
By 1984, Gustavii had the world's largest experience
of diagnostic chorionic villus sampling using an endoscopic
technique. In 96 of his 100 diagnostic cases, laboratory
analysis of the villi was successful. There was a 7%
spontaneous miscarriage rate in his reported series. All
sampling was performed without analgesia and he used
ultrasound to aid in the guidance of the instrument to the
sampling site.
Although vascularised villi could be identified and
removed by this method, the length of time for intrauterine
instrumentation in some cases was over 15 minutes (Personal
Observation at the University of Lund, October 1984).
By 1985, Gustavii had abandoned this method of
diagnostic chorionic villus sampling in favour of trans¬
abdominal chorionic villus sampling and by the end of that
year no major centre in the world was performing chorionic
villus sampling using an endoscopic technique.
B) Biopsy Forceps Combined with Ultrasound
As previously stated in Section 3.3 A, Kazy in 1982
had reported on a series of experimental cases using this
approach. Dumez, by 1984, could report on the results of
120 diagnostic cases (Dumez et aJL 1985) . He used a rigid
forceps of 2 mms in diameter and 20 cms long (originally
designed for paediatric laryngoscopy) combined with real
time ultrasound guidance. A tenaculum applied to the cervix
allowed straightening of the utero-cervical canal as well as
counter traction at insertion of the forceps. These workers
usually obtained villi in up to 3 sampling attempts. Of the
120 diagnostic cases (the majority for fetal sexing and DNA
analysis), there were 41 terminations of pregnancy and 6
spontaneous abortions (a rate of 7.6%).
(Such was the influence of this method in France, that
at the time of the Third International Conference on Chorionic
Villus Sampling and Early Prenatal Diagnosis in December 1986,
this was the preferred method of sampling of French and
Belgian workers, but of no other centre outside these
countries).
METHODS OF TRANSCERVICAL CHORIONIC VILLUS SAMPLING USING
SUCTION ASPIRATION
4.1 INTRODUCTION - Review of Published Papers 1975 to 1984
The technique of transcervical chorionic villus sampling
using suction aspiration owes its origins to Chinese workers,
who in 1975 published the results of their 5 year experience
of transcervical chorionic villus sampling using a metal
cannula (Anshan 1975). The paper examined fetal sex prediction
by the identification of sex chromatin from chorionic villi
cells. One hundred first trimester pregnancies were studied.
The apparatus used to obtain villi was a 3 mm diameter
calibrated metal cannula with an inner fine suction tube,
with a blunt tip which protruded about 1 cm from the end of
the cannula. The inner cannula was connected to a 5 ml
syringe. The cannula was inserted through the cervix and
the proposed sampling site chosen was the part of the
anterior or posterior uterine wall that was the softer.
Once the direction of the cannula was chosen, it was introduced
through the utero cervical canal, to a depth of 6 to 9 cms
from the external os and then when soft resistance was felt,
further introduction was stopped. The inner tube was then
pushed forward 0.5 to 1.0 cm and aspiration performed. The
results of their 100 diagnostic cases are summarised in
Table 1. Of 66 full term deliveries, that they reported,
there were no antepartum or post partum problems in any case.
In 1975 , a paper also appeared by Rhine et a_l, in which
first trimester karyotype diagnosis was attempted in tissue
sampled from the endocervical canal. Their hypothesis was
TABLE 1




Induced Spontaneous Male Female
Male 53 1 2 47 3
Female 46 29 1 3 13
Unknown 1 1
that there existed an area of trophoblastic cell accumulation
at the internal os of the cervix. Using an instrument they
named the Antenatal Cell Extractor (ACE for short), they
successfully obtained tissue from 17 of 21 patients prior to
first trimester termination of pregnancy. The ACE was a
3.5 mm diameter plastic tube with a moveable bulbous tip
which occluded the lumen of the tube during its passage
through the cervical mucous into the region of the internal
os. A small quantity of saline was injected and aspirated
and examined for the presence of trophoblast cells. In 17
patients, cells were karyotyped in 11 and in 4 they were
said to be different from that of the mother using Y body
fluorescence.
In a further series reported in 1979, Rhine and Milunsky
took samples from 53 patients in the first trimester prior
to termination of pregnancy. Fetal chromosomes were
demonstrated in 26 (49%) . This report which formed part of
a book entitled Genetic Disorders and the Fetus, made a case
for first trimester fetal diagnosis as an alternative to
amniocentesis and in particular for aspiration of trophoblast
for chromosomal analysis.
Further interest in first trimester diagnosis was
stimulated by a report by Niazi and colleagues in 1981.
Specimens of villi were initially obtained from first trimester
pregnancies by curettage but in 3 cases, the specimens were
obtained by blind transcervical aspiration using a plastic
Medicut intravenous cannula attached to a 20 ml syringe. Of
these 3 samples, all were successfully cultured and
karyotyped using a novel trypsinisation method while the
origin of the cells obtained was confirmed by examination of
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fetal tissue. In a further paper published in 1981, the
same workers reported on the successful gene analysis of
chorionic villi as a possible technique for first trimester
diagnosis of haemoglobinopathies. Chorionic villi were
obtained from the five women studied by blind transcervical
aspiration using a Medicut cannula.
A refinement of the blind aspiration method was the
guidance of the sampling cannula to the richest source of
villi using ultrasound guidance. This idea, first suggested
by Niazi and colleagues in 1981, was used in a paper
published by Ward and others in 1983, when samples of
chorionic villi were successfully obtained in the first
trimester by passing a cannula through the cervix and into
the placental site using real time ultrasound guidance. All
patients were in the first trimester and anaesthetised prior
to termination of pregnancy. Their study was divided into
three phases. In phase 1, 26 patients between 7 and 12 weeks
gestation had sampling performed using a 16 gauge Medicut
cannula or a specially designed Portex cannula with one or
more side holes. Trophoblast was obtained from 8 patients
(31%). In phase 2, the Portex cannula had an end hole in the
outer plastic sleeve and an inner aluminium obturator which
could be curved appropriately and was visible on the ultra¬
sound scan. A 20 ml syringe provided greater suction and
the presence of villi was confirmed histologically. In 19
patients, between 7 and 13 weeks gestation, trophoblast was
obtained in 17 (89%). In phase 3, the same Portex cannula
was used as in phase 2, but the samples were examined under
a dissecting microscope in the operating theatre, in order
to give instant feedback on the results. Trophoblast was
obtained in 19 of 21 patients (90%) .
The excellent results of the blind transcervical
aspiration reported by the Chinese was encouraging but there
were certain problems with their report. They did not
indicate whether the cannula was bent to accomodate the angl
of the utero cervical canal but they did state that in some
cases a tenaculum was applied to the cervix if the uterus
was ante or retro flexed. There was no reference in their
paper to the number of cases in which aspiration was
attempted but villi was not recovered, so the success and
problems they had encountered prior to their successful
series were not mentioned. The exact materials used in the
construction of the cannula were not detailed except that
the outer tube was metal. Rhine and Milunsky's report of
endocervical aspiration was examined in 1980 by Goldberg
and others. Using the same design of Antenatal Cell
Extractor (ACE), they were unable to demonstrate that any
of the cells they obtained from the 30 patients that they
studied in the first trimester, were fetal in origin. As
an example, they cited the successful culturing of male
fetal tissue from the abortus specimens in 12 patients. In
9 of these cases, the ACE specimens had all been female.
Their conclusion was that their inability to demonstrate a
male karyotype among the cells retrieved with the ACE cast
serious doubts on its usefulness and Rhine and Milunsky's
previous results. They attributed their poor results to
maternal cell contamination which they stated would be a
major problem in the aspiration of trophoblast.
In the paper by Ward describing the Portex cannula,
the method of sampling was described but the number of
insertions necessary to obtain adequate villi varied from 1
to 5 times, and there was no mention of the number of
insertions used in each of the three phases. Similarly,
the position of the placental site in the 66 patients reported
was 'usually found in the posterior uterine wall' and this
may well have influenced their successful results. In phase
2 of their study, when the dissecting microscope was used in
the operating theatre, they did not state how this changed
their sampling when prior knowledge of the success of the
sampling was given to the sampler.
An attempt at comparing the various methods of trans¬
cervical chorionic villus sampling was made by Simoni and
others in 1983. They tested four different sampling methods
for obtaining chorionic villi. Three hundred and seventy-
two women at 6 - 12 weeks gestation who were undergoing
termination of pregnancy were sampled. Table 2 shows the
results of their study. They concluded that the Portex
cannula under ultrasound vision was the method of choice.
Exact details on the number of insertions used for each
cannula was not given but the procedure was repeated not more
than three times. Direct feedback on how successful each
sampling was, was given at the time of each sampling but no
details as to what effect such information had on subsequent
attempts at sampling and on any change of direction of the
cannula to another position within the uterus, was given.
Their technique of transcervical chorionic villus sampling
also differed from that reported by Ward. For each case a
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Series I Hysterscope and Biopsy Forceps
Direct Vision 62 47 (76%)
Series II Abbocath-T 14G
Blind Aspiration 159 102 (64%)
Series III Portex Catheter
Blind Aspiration 48 32 (66%)
Series IV Portex Catheter
Ultrasound Guidance 103 99 (96%)
metal uterine sound was first passed through the endocervix
to locate its tip on ultrasound and assess the direction of
the canal and the length necessary before the placenta was
entered. This having been done, the Portex cannula was then
guided through a pre-determined path into the proposed
sampling site.
The papers of Ward and Simoni popularised the method of
transcervical chorionic villus aspiration using the Portex
cannula and real time ultrasound guidance. Although, in
essence, the apparatus was exactly like the original
instrument described by the Chinese in 1975, the addition of
real time ultrasound proved to be the key to the improvement
in sampling success.
Having obtained samples of the Portex cannula in 1983,
and used it on patients prior to termination of pregnancy,
several problems were encountered. The biggest problem
related to the fact that the outer plastic sleeve of the
cannula which retained its shape as long as the inner
aluminium obturator was in place, did not retain its shape
when the aluminium obturator was withdrawn. As the instrument
usually had to be bent to the appropriate angle to negotiate
the utero cervical canal, withdrawing the bent aluminium
obturator moved the more rigid plastic cannula so that it then
attempted to return to its original shape. The effect of
this was that the cannula tip changed position and its
ultrasonic image was 'lost'. The ability to introduce the
Portex cannula into uterine positions that demanded a more
acute bend on the cannula proved difficult.
In the 1983 paper by Simoni eh: al, the placental position
defined on the ultrasound image was not given for any patient.
There were no details on any difficulties in introducing the
Portex cannula into different placental positions. In
Ward's paper, the placental position was 'usually' found on
the posterior uterine wall. Thus the introduction of the
cannula to this site may have been easier than to anterior
wall placental sites or placental sites near the fundus of
the uterus. The fact that the placenta was usually placed
posteriorly in their study may have favourably biased their
results as the degree of bend on the Portex cannula may have
been kept to a minimum and hence reduced the distortion of
the image of the plastic cannula as the inner metal obturator
was withdrawn. In a more inaccessible placental site, where
the degree of bend on the Portex cannula would be greater,
the risk of significant shift of the plastic cannula and loss
of its ultrasound image could have been greater and led to
less successful chorionic villus recovery.
4.2 PROPOSED STUDIES
With the criticisms of Ward and Simoni's studies in mind,
two metal cannulae were designed and constructed. Familiarity
with the technique of ultrasonically guided transcervical
chorionic villus aspiration was gained in a pilot study
involving 88 aspirations in 32 patients in the first
trimester (Table 3). The pilot study enabled experience with
ultrasound guided transcervical chorionic villus sampling to
be obtained while eliminating operator bias when using the
different cannulae. Thereafter, a randomised study was
TABLE 3


















performed that compared the Portex cannula with the two
personally designed metal cannulae. Other factors that might
be expected to effect successful villus recovery were also
examined.
4 . 3 DESIGN OF CANNULAE
The Malleable Stainless Steel Cannula (MSS) and the
Aluminium Cannula (AL) were compared with the Portex
Trophocan (P) in a random study with special reference to
villus recovery rates and subsequent karyotyping as it is in
the field of chromosomal diagnosis that chorionic villus
sampling is likely to find its widest application.
Two cannulae were designed and constructed (with the
assistance of Rocket of London Limited) to fit six criteria.
(1) The cannula should have a large enough bore that villi
could be aspirated, but small enough overall diameter
to negotiate the endocervical canal, without the need
for prior dilatation.
(2) The cannula should be easily seen on the ultrasound
image especially its tip.
(3) The cannula should have a 'memory', that is, it should
retain its shape when bent but the process of bending
should not narrow the lumen of the cannula.
(4) The material used in the cannula should not be toxic to
the fetus or mother.
(5) The cannula should be able to withstand sterilisation
procedures.
(6) The cannula should be made to fit standard syringe
fittings.
A) Malleable Stainless Steel Cannula (MSS)
(Figure 2)
The features of this cannula fulfil all six of the
criteria, but particular emphasis was placed on the ability
of the tip to be seen on the ultrasound image. The way this wa
done can be seen on Figure 2. The tip was made bulbous but
streamlined, to have an overall olive shape and contained
two opposing holes through which the villi could be sucked.
This design was chosen with the idea that no matter what
position the tip was within the villi, a hole would always
be facing the villi at an approximate 90° angle.
B) Aluminium Cannula (AL)
(Figure 3)
All six criteria were fulfilled by this cannula. The
tip was rounded to avoid trauma at insertion. It also had the
two opposing holes design used in the Malleable Stainless
Steel cannula at the tip. The cannula was of uniform diameter
throughout its length. The characteristics of the two metal
cannulae and the Portex cannula are summarised in Table 4.
4 . 4 SUCTION PRESSURE STUDIES
Each of the cannulae used in the pilot and randomised
studies was assessed as to the negative pressures developed
along them when 5 or 10 mis of 'suction' was applied using
the syringe. No details had been given in any previous study
of the suction pressure developed along the Portex cannula.
I felt that large differences in suction pressure between
the cannulae would bias the results, and therefore this area
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FIGURE 2: MALLEABLE STAINLESS STEEL CANNULA









Portex Trophocan (P) 210 1.13 1.45
Malleable Stainless
Steel (MSS) 210 1.80* 2.70
Aluminium (AL) 210 1.30 2.30
* at olive tip
needed investigation. The measurement of vacuum developed
along the cannulae was performed using a monolithic pressure
transducer, the SENSYM LX0503A.
A diagram of the apparatus used is given in Figure 4.
With the end of the cannula blocked by placing it into a
placenta, the syringe was withdrawn to 5 mis and 10 mis, five
times for each cannula and the pressure read directly from
the Digital Volt Meter attached to the pressure transducer.
The results seen in Table 5 for all cannulae, show the
negative pressures developed along the cannulae. At 5 mis
of syringe withdrawal, the negative pressure is highest for
the Portex cannula and lowest for the Aluminium cannula. At
10 mis, the Aluminium is the lowest and there is no difference
between the Portex and the Malleable Stainless Steel cannulae.
4.5 RANDOMISED CANNULA STUDY
A) Patients
Fifty patients between 8 and 12 weeks gestation, as
assessed on ultrasound measurement (mean 9.4 ± 0.7 weeks)
were enrolled into the study. All were undergoing termination
of pregnancy for non genetic reasons. Informed consent was
obtained in every case. Local ethical committee approval was
obtained. Only viable pregnancies as demonstrated by
ultrasound were studied. One twin pregnancy was excluded
from the study. Sampling was performed in the 24 hours prior
to termination.
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FIGURE 4: TEST RIG FOR SUCTION PRESSURE EXPERIMENT.
CANNULA CONNECTED VIA 3 WAY TAP TO SYRINGE AND
PRESSURE TRANSDUCER. PRESSURE TRANSDUCER




RESULTS OF PRESSURE STUDIES
Pressure (mm.Hg.) *Dead space
Mean S.D. volume
2345 (ml)
P cannula 5 ml -625 -626 -627 -625 -624 -625.0 0.25
syringe 0.6
withdrawal 10 ml -672 -672 -671 -671 -671 -671.4 0.23
MSS cannula 5 ml -613 -612 -614 -614 -615 -613.6 0.32
syringe 0.7
withdrawal 10 ml -672 -672 -671 -671 -671 -671.4 0.23
AL cannula 5 ml -597 -597 -598 -598 -597 -597.4 0.23
syringe 0.8
withdrawal 10 ml -660 -659 -660 -659 -659 -659.4 0.23
P Portex
MSS Malleable Stainless Steel
AL Aluminium
S.D. Standard Deviation
* The dead space volume is the
volume of the 3 way tap, the
cannula and the transducer
cavity.
B) Sampling Method
No anaesthesia or analgesia was used before or during
sampling. A single operator technique was used. With the
ultrasound transducer in the left hand, the cannula was
guided to the sampling site, as identified on the ultrasound
image. Preliminary ultrasonography (using the ADR 4000
Sector Scanner, with a 3 MHz Probe) was carried out to
verify gestational age of the fetus by crown rump length
measurements, and to confirm viability. The placental site
was visualised and assigned to a predominantly anterior or
posterior uterine position.
A sterile Cusco's speculum was passed into the vagina
and the cervix visualised. The position and angle of the
utero cervical canal was assessed and the cannula bent to the
same angle. Using continuous real time ultrasound guidance,
the cannula was passed through the cervix and the image of
the cannula tip observed. Under ultrasound guidance, the
cannula tip was manoeuvered to the placental site which was
entered to a depth of approximately 1 cm, to overcome the
problem of sampling degenerating villi at the placental edge.
Ten millilitres of suction was applied and with a slight
hoovering action and with suction maintained, the cannula was
withdrawn. Each sample was collected into 5 mis of F10
medium containing 20% Fetal Calf Serum, for subsequent
cytogenetic analysis. Each cannula was passed twice and this
was designated a "procedure". Ward had shown that two
passages of the Portex cannula were associated with an 80%
villus recovery rate and therefore it was considered that
this would be sufficient for this study.
C) Random Allocation of Cannula
Prior to the commencement of the study, one of the three
types of cannulae was selected at random and assigned to a
procedure. This random allocation was repeated for 100
procedures. Each patient had two procedures carried out.
The first patient was therefore assigned the first two cannulae
and for the second patient the next two cannulae and so on
(Appendix 1). Thus, in the majority of patients, two
different cannulae types were used but in a proportion of
patients (38%), the random allocation resulted in two cannulae
of the same type being used on a single patient, Portex (3/50) ,
Malleable Stainless Steel (8/50) and Aluminium (8/50). The
random allocation of a cannula type to each procedure
resulted in the Portex cannulae being used in 15 first
procedures and 17 second procedures, the Malleable Stainless
Steel being used in 20 first procedures and 17 second
procedures and the Aluminium being used in 15 first
procedures and 16 second procedures. The variation in the
distribution of cannula types between the first and second
procedures is not significant (F = 1.47 p > 0.05).
After sampling each patient had ultrasonography
performed and the viability of the pregnancy and state of
the sampling site were noted.
D) Cytogenetic Analysis
No direct feedback on success or otherwise of the first
sample was given before the second sample, (constituting the
procedure) was taken. The villus samples were sent to one
of two cytogenetic laboratories and the weight of the villi
obtained for each sample was assessed by the Cytogeneticist
with reference to samples of known wet weight. Three weights
were recorded, < 5 mg, 5-10 mg, > 10 mg.
The villi were treated by the overnight culture method
described by Simoni et a_l or by a direct method as described
by Burgoyne (Burgoyne 1983). Improved chromosome morphology
was obtained by fixing the villi at least overnight. Standard
G-banding techniques were employed. The cytogenetic sampling
was deemed to be adequate if a karyotype was obtained from a
minimum of 2 banded mitoses.
E) Data Recorded
The following data was recorded by the operator (Appendix
2 - sample of data sheet used) parity, gestation by dates,
gestation by ultrasound estimation and placental position.
Patient reaction to the procedure was graded arbitrarily by
the operator from 0 to 3. Nought was no discomfort recorded
and 3 was pain such that the procedure was abandoned.
Difficulty in passing the cannula through the cervix was
recorded on a scale 0 to 3, with 0 being no difficulty and
3 being the added use of a volsellum applied to one lip of
the cervix to give counter traction to the forward movement
of the cannula. Bleeding was graded as none, spotting and
fresh bleeding. This referred to bleeding during or
immediately after sampling. Visualisation of the cannula
(by the operator) on the ultrasound screen during the
procedure was recorded as good, poor and not seen. In practice
however, in no case was the cannula not seen.
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4.6 RESULTS
Table 6 shows the age, gravidity and gestational age as
calculated from crown rump length measurement and indicates
that there is no difference in the groups of patients assigned
to each cannula when these criteria are considered. Each
patient is represented twice, as two procedures were carried
out per patient. The success of a second procedure may have
been influenced by the outcome of the first procedure. How¬
ever, on examination, the success in obtaining villi in a
first or second procedure, irrespective of the cannula used,
was not significantly different (Table 7).
Table 8 and Figure 5 show the villus recovery rate and
the proportion of procedures where karyotypes were obtained
for the three cannulae. Villus recovery (all weights) was
greatest with the Stainless Steel cannula so that with two
passes of a cannula, villi were obtained approximately 68%
of the time. However, the differences between the three
cannulae in successful villus recovery was not significantly
different at the 95% level. When the proportion of karyo¬
types obtained is considered, the Aluminium cannula appears
to be most effective and the Portex cannula the least, and
this difference is significant (0.05 > p > 0.01; Figure 5).
It has been reported previously that 10 mgs of villus
material is required for reliable karyotyping and this is
confirmed by the present study for each of the three cannulae
(Table 9). When the quantity of villi obtained by each
cannula per procedure is examined, it can be seen that the
metal cannulae are comparable and obtain > 10 mgs of tissue
in 27 - 35% of procedures. The Portex cannula in contrast
TABLE 6























CHORIONIC VILLUS SAMPLING SUCCESS PER PROCEDURE
1st procedure 2nd procedure
No. % No. %
Success in obtaining
villi 30 60 34 68 0.7 0.5>p>0.25
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TABLE 8
VILLI AND KARYOTYPE BY CANNULA
Cannula Villi Karyotype Total number
obtained obtained of procedures
N % N %
P 19 59.38 5 15.63 32
MSS 25 67.57 10 27.03 37
AL 20 64.52 15 48.39 31
Total 64 64.00 30 30.00 100
N Number of procedures
P Portex
MSS Malleable Stainless Steel
AL Aluminium
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1 Procedure = 2 Sampling Attempts
Chi Squared p
Villus Recovery 0.5 p>0.05
Karyotype Success 8.3 0.05>p>0.01
FIGURE 5
TABLE 9
KARYOTYPE SUCCESS FOR DIFFERENT QUANTITIES OF VILLI OBTAINED PER PROCEDURE
Quantity of villi (mg)
<5 5-10 >10




N Number of procedures where villi obtained
% Karyotype success
P Portex















only obtains > 10 mgs of villi in 12.5% of procedures (Table 10).
Two main factors that may be expected to influence chorionic
villus sampling are placental site and parity. The difference
in villus recovery by placental site is not significant, but
there is a 16% difference in the mean villus recovery rate
depending on the sampling site. This is shown in Tables 11
and 12 , and diagrammatically in Figure 6. Although a poorer
recovery rate of villi was expected and hence reduced karyo¬
type success in nulliparous patients, because of anticipated
difficulty negotiating the endocervical canal, no such
difference was observed (Table 13).
The ease of insertion of the cannulae, where no difficulty
was encountered (score '0')/ is seen in Table 14. There was
a significant difference in the ease with which the metal
cannulae and especially the Aluminium cannula could be
inserted compared with the Portex cannula. In 11 procedures,
the added use of the tenaculum was needed and it is interesting
to note that all of these related to nulliparous patients
only (Table 15).
The ability to continuously visualise the cannula tip
on the ultrasound screen was recorded for each cannula by the
operator (Table 16). Visualisation of the Malleable Stainless
Steel cannula was best overall, with good visualisation being
recorded in 86% of procedures, compared with 72% with Portex,
reflecting the enhanced ultrasound image of the olive tip,
but the differences statistically between the three cannulae
were not significant.
Pain and bleeding during cannula insertion are recorded
in Tables 17 and 18, and although there was a significant
TABLE 10
VILLUS RECOVERY BY WEIGHT
Procedures where villi obtained Total Number
No
Weight of , ,






13 40.6 10 31.5
12 32.4 12 32.4
11 35.5 12.9
5 15.6 4 12.5
3 8.1 10 27.0




Total 36 36.0 26 26.0 13 13.0 25 25.0 100
N Number
P Portex
MSS Malleable Stainless Steel
AL Aluminium
TABLE 11
VILLI BY PLACENTAL SITE
POSTERIOR ANTERIOR
Cannula Villi Total no. of
^ Villi Total no. of
obtained procedures ° obtained procedures
P 15 22 68.18 4 10 40.00
MSS 17 23 73.91 8 14 57.14
AL 13 19 68.42 7 12 58.33
Total 45 64 70.31 19 36 52.78
P Portex
MSS Malleable Stainless Steel
AL Aluminium
TABLE 12
KARYOTYPE BY PLACENTAL SITE










P 4 22 18.18 1 10 10.00
MSS 5 23 21.74 5 14 35.71
AL 10 19 52.63 5 12 41.67
Total 19 64 26.69 11 36 30.56
P Portex
MSS Malleable Stainless Steel
AL Aluminium
Villi and Placental Site
%
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PARITY AND CHORIONIC VILLUS SAMPLING SUCCESS
Number of previous births 0 1 2 3 4
Number of patients 16 11 16 4 3
Number of procedures 32 22 32 8 6
Villi obtained N 21 16 19 6 3
% 65.6 72.7 59.3 75 50
N Number
TABLE 14
EASE OF INSERTION OF CANNULA INTO THE CERVIX
Score '0' Total number
Cannula
N % of procedures
P 16 50.0 32
MSS 27 73.0 37









EASE OF INSERTION OF CANNULA INTO THE CERVIX
Cannula Score '3' Total number
N % of procedures
P 7 21.9 32
MSS 2 5.4 37
AL 2 6.5 31
N Number
P Portex





Cannula Good visualisation Poor visualisation Total number
N % N % of procedures
P 23 71.9 9 28.1 32
MSS 32 86.5 5 13.5 37





MSS Malleable Stainless Steel
AL Aluminium
* 1 procedure had differing values
for each insertion of the same
cannula therefore was omitted.
TABLE 17
PAIN DURING CANNULA INSERTION
Score '0' Score 0 Total number
Cannula CT, a. ^ .
N % N % of procedures
P 20 62.5 12 37.5 32
MSS 30 81.1 7 18.9 37









BLEEDING DURING CANNULA INSERTION
Cannula Score '0' Score not '0' Total number
N % N % of procedures
P 28 90.3 3 9.7 31*
MSS 30 81.08 7 18.92 37





MSS Malleable Stainless Steel
AL Aluminium
* Uncertain score for 1 patient
** No score recorded for 1 patient
difference in discomfort with the Portex cannula compared with
the metal cannulae, there was no significant difference in
the bloodless sampling rates for all procedures.
The Aluminium cannula proved to be best overall in villus
recovery and subsequent karyotyping. This could be a
reflection of the negative pressure developed along the
cannula when 10 mis of suction were applied. However, the
vacuum pressure studies have shown that the Portex and
Malleable Stainless Steel cannulae have a higher negative
pressure than the Aluminium cannula and this may lead to
fragmentation and destruction of villi more often than with
the Aluminium cannula.
4.7 DISCUSSION
This study compared the Portex cannula with the two
malleable metal cannulae and the results indicate the
superiority of the metal cannulae with respect to villus
recovery and the subsequent preparation of chromosomes from
the samples obtained. The technique of transcervical vacuum
aspiration used, relied solely on the successful guidance of
the cannula into the placental site using real time ultrasound
imaging.
Thus the study examines the inherent qualities of each
cannula studies, matching the method of sampling with that
reported by Ward and Brambati. The randomised study does not
mimic exactly the diagnostic situation where instant feedback
on the success or otherwise of each aspiration can influence
the direction and depth of cannula insertion. From the results
of the randomised study, the preferred instrument for sampling
would be the Aluminium or Malleable Stainless Steel cannula.
The results have shown that a cannula could be passed
through the cervix into the uterus without pain, in up to
93% of patients, of whom 30% were nulliparous. None of the
50 pregnancies studied had a significant bleeding episode up
to the termination and in no case were the membranes ruptured.
No miscarriages were caused by the chorionic villus sampling
in any of the 50 cases. The Aluminium cannula produced the
best karyotype results reflecting the better villus quantity
per sample. The efficacy of any instrument used to obtain
chorionic villi should be judged on the frequency with which
10 mgs or more of villi are obtained for a given number of
passages of an instrument.
Although many authors report villus recovery rates of
up to 90% using transcervical aspiration, they do not usually
quote the karyotype success per passage of cannula which does
not reflect the overall villus recovery rate for amounts less
than 10 mgs. The number of insertions of the instrument
required before adequate amounts of villi are obtained, vary
from once to five times in reported series (Brambati et a_l_
1985 ; Ward et a_l 1983 ; Warren et a_l 1985) . In the method
described and within the limitations already set in this
study, villus recovery rates were no better than 74% when a
cannula was passed twice and the placenta was posteriorly
sited. In those patients, who after randomisation happened
to draw the same cannula for both procedures (4 samples), the
recovery rate remained constant at 89% for all cannulae but
only when a posterior placental site was sampled. This may
explain Ward et aN's results, as in their series the sampling
site was 'usually posterior'.
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Reported series do not state the sampling site when
reporting on their ability to recover chorionic villi using
a particular instrument (Brambati et ad 1985 a; Ward et ad
1983), but this study has shown that with anteriorly sited
placentae, the karyotype success rate is reduced compared to
that from posteriorly sited placentae and this effect was most
pronounced for the Portex cannula. The explanation for this
could be that the loss of ante flexion of the plastic Portex
cannula after removal of the aluminium obturator causes the
tip of the cannula to move away from the villi and towards
the membranes. It may also be that the positive location of
the placenta by ultrasound was incorrect more often when the
placenta was situated anteriorly than posteriorly.
The correct assignment of placental position by ultrasound
is the key to successful chorionic villus sampling. Positive
proof of the accuracy of such an ultrasound assignment can
only be given by recovering villi in diagnostic amounts after
the cannula is seen to enter the specified area within the
uterus. Although the placental site has certain ultrasonically
identifiable characteristics, mistakes in its localisation
could occur. Similarly, the results of any series reporting
on successful villus recovery may be biased if the bulk of
the placentae were in the more favourable posterior position.
In this study, the placenta was assigned to a mainly posterior
position in 32 (64%) and to a mainly anterior position in
18 (36%) .
When guiding any biopsy instrument under real time grey
scale ultrasound guidance through tissue layers, continuous
positive visualisation of the tip of the instrument can be
difficult. The tip of the instrument itself may not be
echogenic enough to distinguish it from the echoes produced
by the tissue layers. This may be improved by enhancing the
echogenicity of the tip of the instrument either by making it
physically large (as in the case of the Malleable Stainless
Steel tip) or enhancing the echoes from the instrument as a
whole and electronically subtracting the echoes from most of
the length of the instrument except the tip (McDicken et a_l
1984) .
These studies indicated that other methods than trans¬
cervical sampling may be necessary to obtain villi when the
placental position was anteriorly placed. Before the
application of transcervical chorionic villus sampling
diagnostically, a study into transabdominal chorionic villus
sampling was undertaken examining the feasibility of the
technique and the effect of placental site on sample weight
as well as comparing transabdominal and transcervical chorionic
villus suction aspiration.
TRANSABDOMINAL CHORIONIC VILLUS SAMPLING USING SUCTION
ASPIRATION
5.1 INTRODUCTION
In a paper discussing future trends in the prenatal
diagnosis of fetal chromosomal disorders, Warburton and
Miller (1972) quoted the transabdominal placental biopsy
technique of Alvarez (1966), as a technique that could be
suitable for use in detecting such disorders. Alvarez (1966)
had published details of 3 cases where the diagnosis of
hydatidiform mole was made by inserting a needle through the
abdominal wall into the pregnant uterus and aspirating molar
vesicles. He had used the same technique in a further 50
pregnancies from 10 to 40 weeks gestation, although no details
of the outcome of these pregnancies was reported.
Aladjem (1969) had used placental biopsies obtained by
transabdominal needle aspiration to investigate pathological
changes in the placenta of pregnancies complicated by
diabetes mellitus, pre-eclampsia and prolonged pregnancy.
A total of 215 third trimester transabdominal samples were
obtained with no established fetal or maternal complications.
These procedures were performed before the advent of real
time ultrasound. Aladjem stated that the limitations of the
technique was in the case of posterior implantation of the
placenta. It was not until the publication in 1984 of a
paper by Smidt-Jensen and Hahnemann that transabdominal
chorionic villus sampling in the first trimester was used
as a diagnostic method for fetal genetic diagnosis.
Smidt-Jensen's paper reported details of 58 women who
had transabdominal chorionic villus sampling attempted prior
to termination of pregnancy. The average gestational age
was 9 weeks. In 95 transabdominal punctures, villi were
successfully obtained in 78 (82%). Samples were obtained
under real time ultrasound guidance. A needle guide was
attached to the ultrasound transducer and the direction of
the needle was predetermined by first identifying the track
it took on the ultrasound screen using a water bath for the
test. The track was marked on the screen with a marker pen.
During transabdominal chorionic villus sampling, the
appearance of the uterus on the screen was then adjusted by
altering the position of the transducer until the proposed
needle track (already drawn on the screen) traversed the
placental area as identified within the uterus. An 18 gauge
150 mm spinal needle was inserted into the uterus (along the
predetermined track) and just into the placental edge. The
depth and direction being observed on the ultrasound image.
Once the placental edge was reached, the trochar of the
18 gauge needle was removed and a 22 gauge, 200 mm spinal
needle was introduced down the 18 gauge cannula and into
the placental substance. A 20 ml syringe, attached to the
22 gauge needle was used to aspirate villi. The syringe
contained a few millilitres of Hanks solution.
No details on the placental position in any of the
58 women tested were given. Details on the villus weights
obtained using this method and the subsequent karyotype
success were not given. Similarly, the quality of the needl
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visualisation and any difficulties in sampling from retro-
verted uteri were not stated.
In October 1984, I visited Hahnemann's unit in Aalborg,
Denmark and the technigue described in their paper was
demonstrated to me by Dr Stein Smidt-Jensen. Having
witnessed the technique, a pilot study was undertaken by me
in Birmingham to assess feasibility and to adapt and modify
the technique to the equipment which was available.
5.2 PILOT STUDY OF TRANSABDOMINAL CHORIONIC VILLUS SAMPLING
The aims of the pilot study were:-
(1) To design equipment that could be used for transabdominal
chorionic villus sampling using available ultrasound
equipment.
(2) To test the equipment in a suitable group of patients.




The ultrasound machine used in the transcervical study,
the ADR 4000 SL, was used. This machine had a 14 mm end-fire
sector transducer (Figure 7). The transducer handle had
longitudinal grooves on it that marked the plane of the
ultrasound beam, helping the operator to correctly orientate
the ultrasound image.
FIGURE 7: THE ADR 4000 S/L WITH 14 MM END FIRE SECTOR
TRANSDUCER
B) Design of Equipment
(i) Needle Holder
This device was designed and constructed by Mr G Hollins
of the Medical Physics Department, Birmingham Maternity
Hospital, to specifications drawn up by myself. Its main
features were:-
(1) An aperture into which the ultrasound transducer could
fit and be held without moving.
(2) A slot, just wide enough for the placement of an 18 gauge
spinal needle (Figure 8).
(3) A spring loaded button which compressed the needle against
the floor of the slot but allowed upwards and downwards
motion of the needle.
(4) Grooves on the transducer holder allowing accurate
matching to the grooves on the transducer so that the
ultrasound beam would always be in a constant position
to the needle slot (Figure 9).
(5) A material that would not damage the ultrasound
transducer yet be sterilisable.
(ii) Guide for the Needle Image
The image of the needle as it passed into the ultrasound
beam was displayed on the screen of the ultrasound machine by
placing the transducer and needle assembly with the transducer
in place just into a water bath.
By correctly aligning the transducer grooves to the
grooves on the holder, the track of the needle on the ultrasound
image was always on the same place on the screen. This place
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FIGURE 8: THE NEEDLE HOLDER ATTACHED TO THE SECTOR
TRANSDUCER WITH THE 18 GAUGE SPINAL NEEDLE
IN PLACE
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FIGURE 9: TRANSDUCER AND NEEDLE HOLDER SHOWING
MATCHING GROOVES
was marked on to a perspex plate placed over the screen of
the ultrasound machine (Figures 10 and 11). Thus, prior to
each transabdominal sampling, the proposed direction of the
needle on the ultrasound image was known by placing the
perspex plate over the ultrasound screen.
During the scanning of a pregnant uterus, the image of
the placenta obtained was manipulated (by moving the plane of
the scan) until the needle track marked on the perspex screen,
was seen to intersect with the placenta.
5 . 4 METHOD OF CHORIONIC VILLUS SAMPLING
Under real time ultrasound guidance and with the needle
track marked, as already described, an 18 gauge, 150 mm spinal
needle was inserted through the abdomen and into the uterus
(via the transducer and needle guide assembly).
The trochar of the 18 gauge needle was removed and the
smaller 22 gauge, 200 mm spinal needle to which a 20 ml
syringe was attached, was introduced down the 18 gauge cannula
and the villi cut and aspirated. The syringe contained a
few millilitres of F10 medium.
A) Patients
Thirty four patients with a mean gestational age of
9.5 weeks (range 8 to 12.5, S.D. 1.2) were recruited.
Informed consent was obtained in each case. All procedures
were carried out under general anaesthesia prior to
therapeutic termination of pregnancy.
There were 33 singleton pregnancies and one twin pregnancy.
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The presence of a fetal heart, placental position and
gestational age of the pregnancy were recorded prior to the
chorionic villus sampling, and the fetal heart was also
recorded after the chorionic villus sampling.
5.5 RESULTS
Villus was successfully recovered from 20 of 34 patients.
The recovery rate appeared to improve with anterior placental
positions compared with posterior placental positions,
(Table 19).
5.6 DISCUSSION
The pilot study proved that the materials designed for
transabdominal chorionic villus sampling using the ultrasound
machine available allowed villus material to be obtained. The
rate at which villi could be successfully aspirated appeared
to be related to the placental position. For diagnostic
chorionic villus sampling, aligning the uterus to the desired
angle by regulating bladder filling might improve successful
sampling from posterior placentae. In this pilot study
altering uterine position by filling the bladder was not
attempted in order to keep the time of the procedure (and
general anaesthetic) to a minimum. One difficulty
encountered was the method of aspiration. Holding the
needle and transducer assembly with one hand, while attempting
to pull out the plunger of the syringe attached to the needle
with the other, proved clumsy. (In Denmark, Smidt-Jensen
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TABLE 19
RESULTS OF THE PILOT STUDY
Villi
Placental position Obtained Not obtained Total
Anterior 13 2 15
Posterior 7 12 19
Total 20 14 34
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at that point usually sought help from a Radiographer who
steadied the needle assembly while he used two hands for
the aspiration).
An improvement in villus aspiration was designed which
allowed the operator to have finger tip control of suction,
while maintaining full control of the needle assembly.
A study comparing transabdominal chorionic villus
sampling with transcervical chorionic villus sampling using
the Aluminium cannula described in chapter 4 was performed.
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A COMPARISON STUDY OF TRANSABDOMINAL AND TRANSCERVICAL
CHORIONIC VILLUS SAMPLING
6 . 1 PATIENTS AND METHODS
Fifty five women, who gave informed consent, were entered
into this study. Local ethical committee approval was obtained.
Four of the 55 women were excluded because preliminary
ultrasonography did not show the presence of a live fetus.
One twin pregnancy was excluded.
The remaining 50 women had a single, live fetus with a
gestational age as assessed by ultrasound measurements
ranging from 7+ to 13 weeks (mean 9.5 ± 1.1 weeks).
6 . 2 EXPERIMENTAL DESIGN
I performed all the sampling and each sampling attempt
was performed twice. Both the transabdominal and transcervical
procedures were carried out under general anaesthesia
immediately before therapeutic termination of pregnancy. In
order to avoid moving the patient excessively while under
general anaesthesia, the transabdominal chorionic villus
sampling was always performed first. To alleviate any bias
in villus recovery that might arise, the placental site was
first localised by ultrasound prior to any sampling and both
methods were used to sample only this allocation of placental
site. Thus, in cases where placental localisation was
uncertain, no bias was given to the transcervical procedure




The ADR 4000 SL was used (section 5.3 A).
6.4 METHOD OF TRANSABDOMINAL CHORIONIC VILLUS SAMPLING
The method used for transabdominal chorionic villus
sampling was identical to that which I had developed in the
pilot study (section 5.4).
6.5 METHOD OF ASPIRATION FOR TRANSABDOMINAL CHORIONIC
VILLUS SAMPLING
Suction was applied from wall suction connected by
plastic tubing (Vygon, Lectro-Cath, 1.5 mm in diameter) to
the 22 gauge needle hub via a paediatric mucous aspirator
and suction was controlled by an R90 plastic connection in
which a small hole had been drilled to allow finger-tip
control of suction. The R90 connection was attached to the
hub of the 22 gauge spinal needle (Figure 12).
6.6 METHOD OF TRANSCERVICAL CHORIONIC VILLUS SAMPLING
The method used was as described in section 4.5 B.
6.7 METHOD OF ASPIRATION FOR TRANSCERVICAL CHORIONIC
VILLUS SAMPLING
Continuous suction, as in the transabdominal method,
was applied (section 6.5).
6.8 CYTOGENETIC ANALYSIS
The villi were collected into sodium bicarbonate
buffered RPMI (+5 I.U. Heparin per ml) and taken directly
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FIGURE 12; PAEDIATRIC MUCOUS ASPIRATOR CONNECTED VIA
VYGON TUBING WITH R90 ADAPTOR (AND HOLE FOR
FINGER CONTROL OF SUCTION) CONNECTED TO NEEDLE
to a laboratory where the villi were dissected out into
fresh medium. The villus weights were estimated with
reference to tubes containing 6 standard samples of villi
of known weight (<5, 5, 5-10, 10, 10-20, >20 mgs). Ten
milligrams of villi are the minimum required for reliable
cytogenetic analysis, although 1 to 5 mgs of villi may also
allow diagnosis, though unreliably, see Table 9, Chapter 4,
Page 4 9.
6.9 RESULTS
The distribution of villus weights obtained by the
transcervical and transabdominal methods are given in
Table 20. When the two sampling methods were compared with
respect to their ability to obtain at least 10 mgs of villi
a highly significant difference was observed (X2M = 13.9,
p<0.001) (McNemar test) (Figure 13). Adequate villus samples
were obtained by transcervical chorionic villus sampling in
35 out of 50 (70%) of the patients, uner these study conditions,
but in only 13 out of 50 (26%) of patients by the trans¬
abdominal approach. Gestational age was not found to be
significantly different between successful and unsuccessful
samples for both sampling methods. Figure 14 shows the
distribution of villus weights obtained from 'anterior' and
'posterior' placentae where "success" was the proportion of
patients in which an adequate sample was obtained. Four
fundal placentae were recorded, and of these, three were
assigned as 'anterior' as the bulk of the placenta was lying




VILLUS RECOVERY BY TRANSABDOMINAL AND TRANSCERVICAL CHORIONIC VILLUS
SAMPLING (CVS)
Number of patients
Transabdominal CVS Transcervical CVS
Villus
weights Posterior Anterior Posterior Anterior
(mg) placenta placenta Total placenta placenta Total
0 5 7 12 6 3 9
<5 5 5 10 1 0 1
5-<10 7 8 15 3 2 5
10-<20 7 4 11 5 3 8
20-<30 1 1 2 3 3 6
30-<40 0 0 0 5 8 13
40-<50 0 0 0 2 3 5
50-<60 0 0 0 0 2 2
60 0 0 0 0 1 1
Total no.


















(>10 mg) 32.0 20.0 26.0 60.0 80.0 70.0
















The transabdominal technique obtained an adequate
sample (10 mgs or greater) in 8 out of 25 posterior placentae
and 5 out of 25 anterior placentae, compared with the
transcervical method, where 20 out of 25 adequate samples
were obtained when the placental site was anterior and 15 out
of 25 when it was posterior (Table 20). However, the influence
of the placental site on the success of these two methods is
not significant (X2 = 1.3, p > 0.05).
6.10 DISCUSSION
This study was designed to examine the efficacy of the
transcervical method of chorionic villus sampling compared to
a transabdominal method rather than an examination of the
'ideal' diagnostic situation, when there are no constraints
on time and the optimal gestational age can be chosen prior
to the chorionic villus sampling procedure. Transabdominal
chorionic villus sampling using the technique described is
characterised by lower weights of villi recovered, compared
with the transcervical method. This is in agreement with
previous findings (Bovicelli et ad 1 986 ; Brambati et a_l
1986). Brambati et ad (1986) employed a larger bore needle,
but the weight of villi obtained was still small, indicating
that needle size does not seem to affect villus recovery.
Prior to this study, I had gained experience with trans¬
abdominal chorionic villus sampling in the pilot study
(section 5.2). My experience of transcervical chorionic
villus sampling was greater, over 200. The numbers of patients
in whom villi of any weight was obtained was not different
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using either method of sampling in this study, thus the
difference in experience of the operator using transcervical
compared with transabdominal chorionic villus sampling does
not appear to have affected overall villus recovery rates.
In this study, the time spent on both methods of
sampling was the same, that is 30 to 60 seconds. However,
in another report on transabdominal chorionic villus sampling,
Smidt-Jensen et al (1986), the average time of suction was
four minutes (1 min 20 sec to 15 min 40 sec). If a longer
application of sampling time is a necessary requirement for
satisfactory villus recovery by the transabdominal method
then it might be expected to be more uncomfortable for the
patient, and may, therefore, require some form of analgesia
or local anaesthesia.
It was my expectation that a transabdominal approach
would be more successful in obtaining chorionic villi from
an 'anterior' placenta than sampling by a transcervical route,
but there was no appreciable difference in obtaining access
to either an 'anterior' or 'posterior' placenta by either
method (Figure 15).
A summary of diagnostic series of chorionic villus
sampling, as reported by Jackson (1986) shows a spontaneous
miscarriage rate following transcervical chorionic villus
sampling as being similar to that following transabdominal
chorionic villus sampling. If this finding is confirmed by
large randomised trials comparing the two techniques, then
it is difficult to see any advantage for transabdominal
chorionic villus sampling, especially for prenatal diagnosis
by DNA or biochemical analysis, in which villus weights of
FIGURE 15







20 milligrams or more are necessary for reliable diagnoses
(Upadhyaya et a_l 1984) .
LABORATORY TECHNIQUES FOR CHROMOSOMAL ANALYSIS FROM CHORIONIC
VILLI
7.1 INTRODUCTION
This chapter considers the value of chorionic villi for
cytogenetic analysis and was derived from a collaboration
between the author and the cytogenetic services.
Although published work existed on the use of chorionic
villi for first trimester fetal diagnosis, for example,
Hahnemann et cQ (1968), Kullander et cQ (1973) and Rhine et_ cLL
(1979), it was not until the publication in 1981 by Niazi
et aj^ of a method of culturing chorionic villi and subsequent
successful karyotype preparation that general interest in the
use of chorionic villi for fetal karyotyping began. Prior to
this, attempts at villus culture had failed because of the
overgrowth in culture of maternal cells. Niazi et al_ (1981)
overcame the problem of maternal cell contamination and the
poor growth of villus cells in culture. Their method relied
on a technique that removed the outer covering of the villus
and exposed the mesenchymal core. The cells of this core
were grown in culture. The cytotrophoblast and
syncytiotrophoblast that covered the villus core were
removed by trypsinisation followed by the passage of the
trypsinised products through fine wire gauze which removed
the maternal cell clusters normally adherent to the outer
covering of the villi.
Simoni in 1983, when repeating this work still
encountered maternal cell contamination (Simoni et al 1983).
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In seeking an alternative to villus culture, they applied a
direct karyotype preparation published in 1972 (Evans et ad
1972). Using this direct method, trisomy 21 was successfully
diagnosed in a fetus at eleven weeks gestation, five hours
after chorionic villus sampling. It was this report that
stimulated worldwide interest in the direct method of fetal
karyotyping using chorionic villi obtained in the first
trimester (Brambati et ad 1983) .
7.2 METHODS OF DIRECT CHROMOSOMAL ANALYSIS FROM CHORIONIC
VILLI
The "direct" method first applied by Simoni et ad
(Table 21) relies on the presence within the cells of the
cytotrophoblast (inner cell layer of the chorionic villus
sheath) of spontaneous mitoses. Spontaneous mitoses constitute
approximately one per cent of cytotrophoblastic tissue from
first trimester chorionic villi (Watanabe et ad 1978).
Within chorionic villi there are many thousands of cyto¬
trophoblastic cells and, therefore, several dozen mitoses
would be present at any one time (Simoni et ad 1986) . These
may be examined directly in metaphase without the need for
tissue culture. Maternal cells which do not exhibit spontaneous
mitoses, would then not interfere with the interpretation of
metaphases obtained from villi and the problem of maternal
cell contamination would be overcome.
Karyotype preparation using Simoni's technique was
criticised by Burgoyne (Burgoyne 1983) because there was a
low mitotic index and poor chromosome morphology as well as
TABLE 21
DIRECT METHOD OF KARYOTYPE PREPARATION FROM CHORIONIC VILLI
Simoni et al (1983)
1. Villi are selected and put into a 60 mm Petri dish
containing 3 mis of RPMI medium without serum.
2. Colcemid is added to the medium to reach a 0.04 pg/ml
final concentration. The villi are left for one hour at
room temperature.
3. The medium is removed and replaced with 5 mis of 1%
sodium citrate solution for hypotonic treatment for
10 minutes.
4. The hypotonic solution is removed and 5 mis of methanol-
acetic acid 3:1 fixative is added for 10 minutes.
5. The fixative is aspirated and replaced with 3 mis of
aqueous 60% acetic acid.
6. After 3-5 minutes, 3 mis of methanol is added.
7. The cell suspension is transferred into a tube and
centrifuged in 0.3 ml of methanol-acetic acid 1:1 fixative.
8. Using warmed slides (40° - 50PC), the cell suspension is
dropped on to each slide and distributed on the surface
of the slide by means of a bent Pasteur pipette.
The slides are air dried for 30 minutes at (40° - 50°C)
before staining. Q.F.Q. banding is used.
many broken mitoses. The implications of this for a
diagnostic cytogenetic service would be that only gross
numerical abnormalities could be detected using Simoni's
method.
The method of Burgoyne proved to be easier and the
metaphases so obtained were amenable to G-banding (Appendix 3
Simoni's technique had always used Q.F.Q. banding which is
a technique not widely used among Cytogenticists in the
United Kingdom. Burgoyne's technique has been adapted by
Dr T Webb of the Clinical Genetics Department, Birmingham
Maternity Hospital (Table 22) and was the method used for
karyotype preparation from villus samples obtained in
Chapter 4.
The essential steps of these methods are contrasted in
Table 23.
A) Application of Webb's Method of Direct Karyotype
Preparation
(i) Patients
Fifteen patients who had transcervical chorionic villus
sampling performed as outlined in section 4.5 B were used.
A minimum of 10 mgs of villi was obtained from each.
(ii) Method
The method of karyotype preparation is described in
Table 22. One slide per patient was selected and examined,
and the metaphases obtained were categorised as follows:-
TABLE 22
DIRECT METHOD OF KARYOTYPE PREPARATION FROM CHORIONIC VILLI
Webb after Burgoyne (1983)
1. The villus sample is placed in a tube containing 5 mis of
medium (Hams F10 with 20% fetal calf serum, glutamine,
penicillin and streptomycin), at approximately 37°C and
transported to the laboratory.
2. The villi are transferred into a dish and examined under
an inverted light microscope when the quantity and quality
of the villi are recorded with reference to villus of
standard weights. Maternal debris, blood clot and decidua
are dissected free with fine forceps from the villi. The
sample is transferred back into a tube.
3. Two drops of colcemid (approximately 0.1 ml (1 pg/ml))
are added to each sample which is then incubated at 37°C
in a water bath for one hour.
4. The villi are then spun down (5 minutes at 1000 r.p.m.)
and the medium (and colcemid) removed.
5. Approximately 5 mis of 1% sodium citrate solution is
added to the villi and whirlimixed. The samples are
incubated for a further 25 minutes (at 37°C) .
6. The villi are spun down (5 minutes at 1000 r.p.m.) and
the supernatant removed.
7. Approximately 5 mis of fixative (3 methanol:1 glacial
acetic acid) are added slowly whilst the samples are
agitated for 30 seconds in a whirlimix.
8. The villi are spun down (5 minutes at 1000 r.p.m.) and
the fixative replaced.
9. The samples are stored in a freezer (at -20°C) overnight
to ensure complete fixation.
10. The villi are spun down (5 minutes at 1000 r.p.m.) and
the fixative removed.
11. 5-10 drops of 60% acetic acid are added and the tube
agitated for 30 seconds.
12. 5 mis of fresh fixative are added to stop the action of
the acetic acid.
13. The cells are spun down and the fixative replaced twice.
14. The cells are resuspended in a few drops of the fixative
and dropped on to cold clean slides and left to air dry
(about 20 minutes).
15. G-banding is then performed using the method outlined in
Appendix 3.
16. When dry, the slides are made permanent and can then be
examined under the light microscope.
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TABLE 23
THE THREE METHODS OF DIRECT KARYOTYPE PREPARATION COMPARED
Simoni et al Webb
(after Burgoyne)
Steps




































































warmed slides cold slides
9 Q.F.Q.
banding
G-banding G-banding Identification of
individual chromosomes
ANALYSABLE suitable for numerical and/or banding analysis
(Figure 16)
POOR not suitable for analysis due to poor chromosome
morphology and/or overlapping chromosomes
BROKEN obviously broken metaphases
(iii) Results
Table 24 gives the results for the 15 patients.
(iv) Discussion
Less then 10 per cent of the total number of cells in
metaphase were analysable and the remainder were poor or
"broken".
The quality of chromosomes obtained using this method
was inferior to those karyotypes obtained from amniotic fluid
cultures (Figures 17 and 18). It was felt that particular
stages in the technique could have resulted in the high number
of broken mitoses and poor metaphase spreads. Flori in 1985,
described a modification of the direct chromosome technique
in which the villi were rehydrated in stages using first 100%
alcohol, then 70% alcohol, then 50% alcohol and finally water
and using this technique, it was found that the number of
interpretable metaphases obtained increased by a factor of
five compared with Simoni's technique (Flori et aJL 1985).
This rehydration step was introduced to the direct method in
use and the method of making slides revised (Evans 1972).
The final method, known as the "Flori" technique is given
in Table 25.
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FIGURE 16: ANALYSABLE METAPHASES USING A DIRECT PREPARATION
FROM A CHORIONIC VILLUS SAMPLE (KARYOTYPE 46,XX)
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TABLE 24
RESULTS OF DIRECT KARYOTYPE PREPARATION USING WEBB'S
MODIFICATION OF BURGOYNE
Patient Quality of Metaphases
Analysable Poor Broken Total
1 0 1 0 1
2 3 24 13 40
3 0 0 0 0
4 7 8 20 35
5 5 44 7 56
6 0 16 5 21
7 0 0 0 0
8 0 5 4 9
9 0 1 3 4
10 0 0 0 0
11 0 0 0 0
12 0 0 1 1
13 1 1 3 5
14 3 19 4 26
15 1 2 4 7
Total 20 121 64 205
Mean 1.3 8 .1 4 . 3 13 . 7
Standard




% of total 9.8 59.0 31.2
COMPARISON OF CHROMOSOME PREPARATIONS
FIGURE 17: CHORIONIC VILLUS SAMPLE DIRECT PREPARATION
FIGURE 18: AMNIOTIC FLUID CULTURE
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TABLE 25
MODIFIED TECHNIQUE FOR DIRECT KARYOTYPE PREPARATION
After Flori et al (1985)
1. Chorionic villus samples are collected in RPMI 1640
medium with 5 IU/ml heparin 0.1 mM/ml glutamine,
100 IU/ml penicillin and 100 pg/ml streptomycin and
buffered with sodium bicarbonate.
2. The sample is examined using a dissecting microscope
and the villi dissected out and washed in RPMI 1640
medium without heparin and 10% fetal calf serum (FCS).
3. 0.1 ml colcemid (10 pg/ml) was added and the villi
incubated at 37°C for 1 hour.
4. The villi are centrifuged at 1000 r.p.m. for 5 minutes
and the supernatant discarded and replaced with 5 mis
prewarmed 1% sodium citrate solution for 20 minutes at
3 7 °C.
5. This is removed after centrifugation and the villi are
fixed in 10 mis 3:1, absolute methanol: glacial acetic
acid. The fixative is changed and the tubes placed in
a deep freeze (-20°C) for at least 45 minutes before
slide preparation.
6. Before dissociation the villi were rehydrated in stages.
The fixative was removed after centrifugation and
approximately 3 mis methanol added, then deionised water
is added 1 ml at a time to a concentration of 50%. A
further 10 mis of water was added after the removal of
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the methanol/water after centrifugation at 2000 r.p.m.
for 5 minutes. The villi were centrifuged once more
and the supernatant poured off and 10 drops of 70%
acetic acid added to the tube.
7. After 4 minutes slides are prepared by placing one drop
of cell suspension at one end of each slide and immediately
sucking it up and placing it adjacent to the first drop
and again sucking it up immediately, this is repeated
three more times (Evans et ad 1972). Slides are warmed
on a hot plate at approximately 45°C.
8. The slides are G-banded after 'ageing' overnight in an
oven at 50°C, as outlined in Appendix 3.
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B) Application of "Flori's" Method of Direct Karyotype
Preparation
(i) Patients
Eighteen patients, who formed part of the study reported
in section 7.5, were used. The method of chorionic villus
sampling was that described in sections 4.5 B and 6.5.
(ii) Method
One slide per patient was examined in order to be
consistent with previous data using Webb's technique. The
metaphase spreads were categorised as previously outlined.
(iii) Results
Table 26 shows the results from the 18 patients.
Table 27 compares Webb's with "Flori's" technique.
(iv) Discussion
Using the method of "Flori", the number of analysable
divisions has substantially increased as have the total
number of divisions (from 10 to 23%). The "Flori" technique
also results in relatively less "poor" divisions (from 59 to
37%) but more broken divisions (from 31 to 40%), so that if
the technique is to be improved, ways must be found of
reducing the breakage of mitotic spreads.
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TABLE 26
RESULTS OF DIRECT KARYOTYPE PREPARATION ("FLORI" METHOD)
Patient Quality of Metaphases
Analysable Poor Broken Total
1 2 1 0 3
2 0 0 1 1
3 10 13 22 45
4 8 15 39 62
5 11 19 17 47
6 8 16 11 35
7 10 9 4 23
8 13 18 20 51
9 6 24 13 43
10 6 12 20 38
11 7 7 3 17
12 18 25 20 63
13 3 9 2 14
14 4 6 6 16
15 8 9 18 35
16 2 5 2 9
17 8 19 25 52
18 12 15 15 42
Total 136 222 239 596
Mean 7.6 12.3 13 . 3 33 .1
Standard








MEAN NUMBER OF DIVISIONS PER SLIDE
Method Analysable Poor Broken Total
Webb 1.3 8.1 4.3 13.7
"Flori" 7.6 12.3 13.3 33.1
PROPORTIONS OF DIVISIONS PER SLIDE (AS % OF TOTAL)
Method Analysable Poor Broken
Webb 9.8 59.0 31.2
"Flori" 22.8 37.3 40.1
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7.3 SHORT TERM CULTURE OF CHORIONIC VILLI
It was purported that whole villi incubated in medium
at 37°C for 1-2 days and then prepared by a direct method
had improved chromosome morphology, thus reducing the time
spent by the laboratory in examining the material.
There have been few reports where a direct preparation
and a short term culture method for processing chorionic villi
have been compared. Figures are presented in Terzoli et all
1985, that indicate a peak in the number of mitoses between
49 and 52 hours incubation. Stewart et aH 1986, have
reported that although there is a slight decrease in the
average number of metaphases after short term incubation
compared to direct preparation the chromosomal morphology
was improved after short term incubation. However, in
Stewart et a_l 1986 , no figures were given and in Terzoli
et aH 1985, the quality of the metaphases examined was not
reported.
7.4 A COMPARISON STUDY BETWEEN "DIRECT" AND SHORT TERM CULTURE
A) Introduction
A study was conducted comparing the direct method of
Flori, Table 25, with a 24 hour and 48 hour short term culture
for chorionic villi, to assess which method was best in terms
of the quality of metaphase spreads obtained that would be
useful for fetal karyotyping.
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B) Patients
Twenty patients undergoing transcervical chorionic villus
sampling for diagnostic purposes were used. Their gestational
ages ranged from 9 to 12 weeks.
Chorionic villi were collected via a transcervical
technigue using the Aluminium cannula by the method described
in section 4.5 B.
C) Methods
The method of karyotype preparation was that outlined
in Table 25.
Ten to fifteen milligrams of villi were placed in 5 mis
of RPMI with 10% Fetal Calf Serum (F.C.S.) in each of 3 tubes.
The villi for the 24 hour and 48 hour short term cultures
were incubated at 37°C before harvesting and those for direct
preparations were processed immediately.
0.1 ml colcemid (lpg/ml) was added for 1 hour (direct
preparations) or 2 hour (short term cultures).
Slides were G-banded (Appendix 3) after "ageing" over¬
night at 60°C. For the purposes of this study, two slides
were scanned from each method per patient and all metaphases
were categorised as outlined in section 7.2 A (ii).
D) Analysis of Data
The data were analysed following JY transformation by a
two-dimensional, mixed model analysis of variance. This test
allows greater discrimination between variables than alternative
tests, for example, a paired t test (Sokal et ad 1981). The
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"methods" were considered to be a fixed effect and the
"patients" and replicates as random effects. The F values
(Tables 28 and 29) are variance ratios obtained by dividing
the mean squares of the "methods" or "patients" terms by the
interaction. The interaction term (Tables 28, 29 and 30)
arises due to the effect of the "patients" on the outcome
of the "methods". The variances (Table 30) are calculated
from the mixed model ANOVAR and the proportions of each in
relation to the total variation are given as a percentage.
E) Results
The results show that the mean number of analysable
divisions per slide ranges from 6.05 in samples prepared by
the direct method to 3.30 following a "48 hour" incubation
(Table 31). The variation about these means, however, is
substantial and the differences between the methods are
found to be not significant. There is also no significant
difference between "patients" (Table 28 (i)). The third
component of variation, the interaction term, is highly
significant (Table 28 (i)) and accounts for 64.8% of all
the observed variation (Table 30).
The interpretation of this, is that either
A. different patients respond more favourably to different
methods
OR
B. that it is the random distribution of 'good quality'
villi, destined to produce good quality metaphases,
within the three tubes set up for the three methods, that
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TABLE 28
AN ANALYSIS OF THE VARIATION FROM DIRECT AND SHORT TERM
CULTURE METHODS
(i)

















F p F p F p
2.10 n.s. 7.14 ** 11.68 ** 7.25 **
0.88 n.s. 1.77 n.s. 1.89 n.s.1.19 n.s
5.20 ** 4.95 ** 4.01 ** 7.50 **
n.s. p>0.05, not significant
** p<0.01
Data transformed by yY.
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TABLE 29






































n.s. p>0.05, not significant
** p<0.01
Data transformed by JY.
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TABLE 30























Variation as a % of the total is given in brackets
111.
TABLE 31
THE NUMBER OF METAPHASE CELLS IN CHORIONIC VILLI PREPARED
BY DIRECT AND SHORT TERM CULTURE METHOD
DIRECT "24 hour" "48 hour"
ANALYSABLE
Mean number* 6.05 4.78 3.33
Total number 242 191 133
Proportion (%) 23.11 30.41 36.44
POOR
Mean number* 11.10 6.38 3.95
Total number 443 255 158
Proportion (%) 42.31 40.61 43.29
BROKEN
Mean number* 9.05 4.55 1.85
Total number 362 182 74
Proportion (%) 34.57 28.98 20.27





* per slide, 20 patients, 2 slides per sample
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leads to some patients apparently responding more
favourably to one method compared to another.
If the sample from any one patient responds differently
with respect to the three cytogenetic methods, then for any
diagnostic sample for fetal karyotype analysis, a direct and
short term culture should be set up. If, however, it is the
random distribution of 'good quality' villi between the
methods that leads to the highly significant interaction term,
then for any diagnostic case, whichever method is convenient
for the laboratory can be used.
In order to test which of these hypotheses, A or B, was
applicable, a further study applying one method to each of
3 tubes containing villi from a single patient was performed.
7.5 APPLICATION OF A SINGLE METHOD OF KARYOTYPE PREPARATION
TO A SPLIT SAMPLE OF CHORIONIC VILLI
A) Patients
Twenty pre-termination patients (8-12 weeks gestation)
had transcervical chorionic villus sampling performed as
outlined in section 4.5 B. In all cases formal consent was
given.
B) Method
The method of collection and karyotype preparation was
that given in Table 25. The sample of villi from each patient




Table 32 shows the number of metaphases obtained in
each of the 3 tubes prepared by a single method. If
hypothesis A was correct then one would expect the "methods"
and interaction terms to be not significant and the "patient"
variation to be significant. If hypothesis B was correct,
one would predict both the "method" and "patient" effects to
be not significant but the interaction term would remain
significant (Table 29 (i) and (ii)). An analysis of the
number of analysable divisions is given in Table 29 (iii)
and shows significant "patient" (p<0.01) and interaction
terms (p<0.01), which fits with neither model precisely.
These two components account for 28% and 40% of the total
experimental variation, respectively (Table 30).
7.6 DISCUSSION OF STUDIES 7.4 AND 7.5
When making a cytogenetic assessment of a laboratory
technique, it is the number of analysable cell divisions
obtained rather than the total number of divisions that are
important. In the study 7.4, more analysable divisions were
present per slide than in the results from study 7.5 (Tables
31 and 32). This may be due to the less than ideal
circumstances under which the pre-termination specimens were
obtained and to the disparity between the average gestational
age of the samples (10 - 11 weeks in the first study 7.4 and
8-9 weeks in the second study 7.5).
The variation observed between the samples in 7.4 may
be due to three factors: an effect of the methods, variation
arising from the random allocation of different quality villi
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TABLE 32
THE NUMBER OF METAPHASE CELLS IN CHORIONIC VILLI PREPARED




Mean number* 3.60 3.05 2.05
Total number 144 122 82
Proportion (%) 25.35 22.30 20.71
POOR
Mean number* 6.13 6.48 5.48
Total number 245 259 219
Proportion (%) 43.13 47.35 55.30
BROKEN
Mean number* 4.48 4.15 2.38
Total number 179 166 95
Proportion (%) 31.51 30.35 23.99
TOTAL NUMBER OF DIVISIONS
Mean number* 14.20 13.68 9.90
Total number 568 547 396
* per slide, 20 patients, 2 slides per sample
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between tubes (hypothesis B) and a difference between the
"patients" in their response to a method (hypothesis A).
The analysis of the data from 7.4 shows no significant
difference between the three methods. An apparent trend is
observed in the summed data in Table 31 with higher numbers
of analysable, poor and broken metaphase cells in villi
prepared by the direct method compared to the short term
culture methods. This is similarly observed between the
three tubes in 7.5 (Table 32), even though they were all
processed by the same method. Thus, if there is any advantage
in using one of these methods, it is small. Terzoli et aJL
(1985) examined 8 villus specimens over a range of incubation
times (2 hours to 52 hours) and observed a relatively
synchronised burst of mitoses occuring after 49 hours
incubation. In this study, the incubation times did not
exceed 45 hours which may account for there being no
corresponding increase in mitotic index in the samples
prepared by the "48 hour" culture method in 7.4.
Following 7.4, two models were proposed as possible
explanations of the interaction between the "patients" and
the "methods". The results from 7.5 do not confirm either
hypothesis A or hypothesis B, and the data (Table 29)
indicates that the observed experimental variation may
therefore be composed of both random "within a patient"
variation (hypothesis B) and differences between "patients"
in their response to a technique (hypothesis A)(Tables 29
(i), (ii) and (iii)).
The largest contributing factor to the observed variation,
when comparing these methods, appears to be a random within
116 .
"patient" variation (hypothesis B), which accounted for
approximately 40% of the total variation 7.5 (Table 30).
This variation may be due to the physiological differences
known to occur between the villi within a placenta (Kaufmann
1982). Upadhyaya et ad (1987) recently examined the gross
morphology of villi within placentae in relation to the
sampling site and the diagnostic result. Within a placenta
they recognised two villus types; a stringy form and a
budding form. Their data shows that in direct preparations
the presence of budding villi was associated with adequate
to very good preparations and the stringy villi tended to
produce poor preparations.
The variation that may be attributed to the difference
between the "patients" in their response to the methods
(hypothesis A) and which generated 28% of the total variation
recorded in 7.5, may also be due to gross physiological
differences. The villi at the periphery of the placenta are
known to degenerate and so it is not unreasonable to expect
the sampling site to affect the quality of a whole sample.
The stage of development of the placenta may also affect the
type of villi obtained, for example, the gestational ages of
the samples in these studies range from 8 to 12 weeks. The
data presented from the study by Terzoli et ad (1985)
illustrates similar variation between the "patients" in their
response to a treatment. Following incubation, a doubling
of the mitotic index was found to occur between 49 and 52
hours incubation, but only 4 of the 8 samples peaked within
one time period (50 hours). Care must be shown when
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interpreting the findings of studies comparing cytogenetic
methods where this "patient"/"method" interaction has not
been taken into account.
Cytogenetic laboratories should accept that differences
in the guality of the villi in any one placenta will result
in unpredictability in processing this material and it may be
that all direct and short term culture methods, which rely on
the naturally occuring mitotic index, will be inconsistent.
Given the occurence of a difference between the patients in
their response to a method, it appears that where sufficient
villi and staffing resources are available, it would be
advisable to prepare the villus samples by more than one
direct or short term culture method.
Using the methods outlined in these studies, there has
been 100% successful karyotyping from chorionic villus
samples, outlined in Chapter 8.
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A DIAGNOSTIC SERIES OF FIRST TRIMESTER CHORIONIC VILLUS
SAMPLING PROCEDURES
8.1 A) INTRODUCTION
This chapter describes one hundred consecutive patients
who had diagnostic chorionic villus sampling performed between
1985 and 1987, using the techniques given in detail in
chapters 4, 5 and 6. Where karyotype analysis was performed,
the laboratory techniques described in chapter 7 were used.
All chorionic villus sampling procedures were carried out by
me at the Birmingham Maternity Hospital. This hospital is
situated in Central Birmingham Health District, one of twenty
two districts, comprising the West Midlands Regional Health
Authority. This, the largest Health Authority in the United
Kingdom, serves a population of nearly six million people.
The patients described in this chapter were referred from
throughout the West Midlands Regional Health Authority and
in some cases from beyond its boundaries.
Although there has been a screening programme for certain
fetal abnormalities using amniocentesis (since 1976) and
serum alpha-fetoprotein blood testing (since 1981), the
West Midlands Regional Health Authority has one of the
lowest rates of prenatal screening among Health Authorities
in England and Wales. In 1986, 2% of pregnancies had
prenatal screening in the West Midlands compared with 5% of
pregnancies in the Trent, Wessex or Mersey Regional Health
Authority areas (ACC 1986).
A low uptake of prenatal screening services may be
due to lack of public knowledge of what is available and
late presentation for such tests, but may also be due to
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lack of awareness by medical personnel of which screening
tests are available and which patients are eligible.
The aim in setting up diagnostic chorionic villus
sampling was to successfully diagnose fetal abnormality
before twelve weeks gestation, such that where termination
of pregnancy was found to be indicated it could be performed
before thirteen weeks gestation. The benefits of such an
approach have already been described in section 3.1.
Faced with a background of low uptake of existing
prenatal diagnostic tests where the timespan for testing was
relatively long (amniocentesis and ultrasound), I realised
that the take up of chorionic villus sampling, in which the
timespan for testing was short (9 - 11+ weeks gestation),
might be even less because of the late presentation of many
pregnant patients to their doctor. An important part of
setting up diagnostic chorionic villus sampling as a prenatal
test would be increasing awareness of the test by the public
and also those professionals involved in the health care of
pregnant women.
8.1 B) INCREASING PUBLIC AWARENESS OF CHORIONIC VILLUS
SAMPLING
By contacting journalists, several articles on prenatal
diagnosis and chorionic villus sampling appeared in local
Birmingham newspapers in 1985 and 1986. This was followed
by two news items on chorionic villus sampling put out on
local television throughout the Region.
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Those families known to the Regional Clinical Genetics
Services to be at risk of congenital diseases for which
chorionic villus sampling could be a useful prenatal
screening test, were made aware that a new test was available
but early attendance in pregnancy was important. Efforts
were made to obtain blood for DNA analysis from children
with Cystic Fibrosis and their families such that, when
pregnancies occurred in such families, DNA analysis for
prenatal diagnosis would be possible.
Using the Muscular Dystrophy Register (held in the
Department of Clinical Genetics), families who had expressed
an interest in fetal sexing and chorionic villus sampling
in any future pregnancy were also contacted about early
attendance in pregnancy.
8.1 C) INCREASING MEDICAL PERSONNEL'S AWARENESS OF
CHORIONIC VILLUS SAMPLING
In 1985, a Chorionic Villus Sampling Study Group
which met monthly in 1985 and quarterly from 1986, was set
up. Its function was to bring together the medical and
laboratory workers involved in chorionic villus sampling
research in Birmingham. It consisted of four Obstetricians,
the two Regional Clinical Genetics Consultants, the two
Consultant Cytogeneticists from the two Regional laboratories
in Birmingham, as well as those laboratory workers and field
workers directly involved in prenatal screening.
The group fostered research into chorionic villus
sampling as well as critically evaluating the results of
such work. It appraised articles on chorionic villus
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sampling in the medical literature. It produced a document
explaining the techniques of chorionic villus sampling and
outlining the work on this subject being carried out in
Birmingham, as well as indicating the method of referral
of eligible patients for this test.
This document was circulated to all Consultant
Obstetricians in the West Midlands Regional Health Authority
area and later to all General Practitioners in the area.
Throughout the years 1985 to 1987, lectures on chorionic
villus sampling were given to interested health personnel
throughout the West Midlands and in December 1985, the
Second International Conference on Chorionic Villus Sampling
and Early Prenatal Diagnosis was hosted in Birmingham.
8.2 ORGANISATION AND PROCEDURES OF THE CHORIONIC VILLUS
SAMPLING CLINIC
A) Patient Referral
One hundred patients are described, who were referred
from throughout the West Midlands Regional Health Authority
area.
Forty-two patients had chorionic villus sampling
performed where the sole indication was maternal age. By
1986, Regional policy was to offer prenatal testing for
chromosomal abnormalities to women of 37 years or over but
by August 1987, this had dropped to 35 years. Thirty-seven
patients had been randomised to receive chorionic villus
sampling as part of the Medical Research Council (MRC) Trial
comparing amniocentesis with chorionic villus sampling. All
these women were referred via their General Practitioners
and in some cases, their Obstetricians.
122.
The Regional Clinical Genetics Service referred three
women with familial translocations, fourteen women for fetal
sexing (one patient had chorionic villus sampling performed
in successive pregnancies) and twelve women for fetal DNA
analysis.
Twenty-six women, who had had a fetus or child with a
chromosomal abnormality, were referred from Obstetricians
and the Regional Clinical Genetics Service.
Three women were referred via the Biochemistry Department
of the Birmingham Children's Hospital.
B) Staff of the Clinic
All chorionic villus sampling procedures were performed
by the author. Ultrasonography was performed either by a
Radiographer or the Principal Medical Physicist at the
Birmingham Maternity Hospital. A State Registered Nurse
and gualified Health Visitor assisted in all procedures, as
well as being part of the counselling team for all patients
referred. Two Cytogeneticists experienced in the assessment
of chorionic villi and in karyotype procedures were present
at all samplings to immediately advise the operator on the
guality of the villus samples obtained.
C) Transcervical Chorionic Villus Sampling
The preferred method of chorionic villus sampling was
transcervical but in certain cases described individually
(section 8.4), a transabdominal procedure was used.
The eguipment used for each procedure is listed in
Appendix 4. An Aluminium cannula described in chapter 4
and illustrated in Figure 3 was used.
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The method of sampling was that described in chapter 6,
cleansing of the vagina prior to the procedure was performed
using 5% Hibitane. Suction was provided by an Electromagnetic
Piston Pump (The Reciprator), Figure 19, which could deliver
a suction pressure of 70 cms of water maximum (700 mm Hg).
The ultrasound machine used to assess all patients prior
to chorionic villus sampling was the General Electric RT 3000
using its 5.0 MHz sector probe. This machine was also used
for all transcervical procedures.
D) Transabdominal Chorionic Villus Sampling
Transabdominal chorionic villus sampling was performed
using the equipment and method described in chapter 6.
The needle used was an 18 gauge 150 mm spinal needle
(Needle Industries, Redditch). 1% lignocaine was infiltrated
into the skin (5 mis maximum) in all cases, prior to
abdominal puncture.
E) Bacteriological Assessment
The result of a bacteriology swab taken from the
endocervix and upper vagina was known no less than 48 hours
prior to chorionic villus sampling in all patients.
Bacteriology swabs were either sent to the local laboratories
by referring Clinicians or if this had not been achieved prior
to their assessment at the Birmingham Maternity Hospital,
swabs were sent to the Bacteriology laboratory, Birmingham
Maternity Hospital. In the laboratory, all swabs were
examined for the presence of aerobic and anaerobic organisms
as well as fungae. Specific swabs for viral culture were
FIGURE 19: RECIPRATOR SUCTION APPARATUS CONNECTED VIA
VYGON TUBING TO PAEDIATRIC MUCOUS ASPIRATOR
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not requested from any patient, as in none of our cases was
a history of herpetic infection obtained. Cultures for
Chlamydial organisms are not offered as a routine at the
Bacteriology laboratory, Birmingham Maternity Hospital.
In a diagnostic case of transcervical chorionic villus
sampling performed in 1984, before this reported study, a
septic abortion occurred two weeks after sampling in a
patient, in which a preliminary bacteriological report had
shown no significant growth. A second report had shown a
growth of Bacteroides organisms but by the time specific
treatment could be instigated the septic process had
commenced. I, therefore, made it a policy that in all women
in whom transcervical chorionic villus sampling was performed,
irrespective of the preliminary bacteriological report,
metronidazole (Flagyl) 200 mgs, three times a day was given
after sampling and continued for seven days. This dose of
metronidazole in pregnancy has never been proven to be
teratogenic in over twenty seven years of clinical use
(ABP1 , 1984) .
Results
Table 33 shows the bacteriological results in the 100
patients.
All patients who had organisms grown prior to chorionic
villus sampling had appropriate antimicrobial chemotherapy
as indicated on the sensitivity report from the laboratory.
Four of the five patients who had a spontaneous abortion
following chorionic villus sampling had no significant growth
























* 1 also had a growth of Peptostreptococcus
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had a growth of Gardnerella Vaginalis (patient 71). All
5 had received metronidazole in the appropriate dosage
following the procedure. Similarly, in patient 56 who
delivered at 26 weeks gestation, there was no growth on
bacteriological culture of vaginal swabs prior to her
chorionic villus sampling procedure and she also received
metronidazole after the procedure.
F) Rhesus Blood Grouping
All patients having chorionic villus sampling had Rhesus
blood grouping performed and the result available prior to
the procedure.
Any patient found to be Rhesus Negative had a Kleihauer
test performed after sampling and an estimation of feto-
maternal haemorrhage made.
The standard dose of Anti-D immunoglobulin (250 IU),
given to all Rhesus Negative patients after the procedure,
was therefore adjusted in line with the Kleihauer report.
Results
Thirteen women were Rhesus Negative and 87 were Rhesus
Positive. Of the 13 women who were Rhesus Negative, two
(cases 35 and 56) had estimated feto-maternal transfusions
of 25 mis and 5 mis respectively by Kleihauer estimation.
Patient 35 received a total of 2500 IU of Anti-D and patient
56 received a further 250 IU of Anti-D.
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G) Ultrasound Assessment
The gestation of the diagnostic series and the placental
location is given in Tables 34 and 35. Gestation was
calculated in all cases by measurement of fetal crown rump




GESTATIONAL AGE AT SAMPLING
Gestational age (weeks) Number














8.3 TRANSABDOMINAL CHORIONIC VILLUS SAMPLING
Seven patients had transabdominal chorionic villus
sampling performed. The indications for the procedure and
the outcome are detailed individually.
Table 36 gives the villus weights for the 7 patients.
Patient Number 22 A 27 year old woman was referred via the
Regional Clinical Genetics Service for fetal sexirig. She had
had 2 previous pregnancies. The first was a spontaneous
miscarriage at 6 weeks gestation and the second was a mid-
trimester termination of pregnancy at 20 weeks gestation
following an amniocentesis. That fetus was male. There was
a family history of the Opitz (BBB) syndrome which is sex
linked. Males with this condition have several abnormalities
including mental retardation. The Clinical Geneticist had
estimated a carrier risk of 1 in 4, and a chance of 1 in 8
that a male would be affected (Dr M Hulten, Consultant
Clinical Cytogeneticist, East Birmingham Hospital - Personal
Communication).
Preliminary high vaginal swab showed no growth. Blood
group was A Rhesus Positive. At sampling a single fetus,
crown rump length 5.3 cms equivalent to 11% weeks gestation,
was seen. The placental site was anterior. The uterus was
in an erect position and anteflexed. Transcervical chorionic
villus sampling was attempted twice but satisfactory quantities
of villi could not be obtained. Transabdominal chorionic
villus sampling was performed and 5-10 milligrams of villi,
suitable for analysis, was obtained on one aspiration.
















* Four subsequently had transabdominal CVS.
Three had amniocentesis.
** Includes the four who had unsuccessful transcervical CVS.
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After further counselling by the Regional Clinical
Genetics Service, the couple decided to continue with the
pregnancy.
The patient had a spontaneous delivery of a live boy,
3.91 kilograms in weight, at 40 weeks + 2 days gestation.
There were no neonatal problems and the male child appears
to be normal at follow up.
Patient Number 60 A 30 year old woman who had given birth
to one male child with primary Trisomy 21. She requested
chorionic villus sampling and was referred by her General
Practitioner.
Preliminary high vaginal swab showed no growth. Blood
group was O Rhesus Positive. At sampling a single fetus,
with a gestational age equivalent to 10-11 weeks, was seen.
The placental site was posterior and fundal. Two attempts
at transcervical chorionic villus sampling were unsuccessful
as the bulk of the placenta was in a fundal and inaccessible
position. She was given metronidazole, 200 mgs twice daily,
for 7 days, and 5 days later at 11 weeks gestation underwent
transabdominal sampling when 10 milligrams of villi were
obtained.
The fetal karyotype was 46,XX.
She had a spontaneous delivery at 40 weeks + 1 day
gestation, of a live female, 3.2 kilograms in weight. There
were no neonatal problems.
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Patient Number 77 This 39 year old woman was referred by
her Obstetrician for prenatal screening. She entered the
MRC trial and was allocated chorionic villus sampling.
Preliminary high vaginal swab showed Gardnerella
Vaginalis and she was treated with metronidazole, 200 mgs
three times a day, for 7 days, starting on the day of sampling.
She was Rhesus Positive. On ultrasonography, the fetus had
a crown rump length of 3.9 cms equivalent to 10-11 weeks
gestation. A cystic fibroid was noted posteriorly on the
uterine wall distorting the endocervical canal.
Consequently, she had transabdominal chorionic villus
sampling and 15 milligrams of villi were obtained with one
aspiration.
The fetal karyotype was 46,XX.
She had a Caesarean Section at 37 weeks and 4 days
gestation. A live female, 3.15 kilograms in weight, was
delivered. There were no neonatal complications.
Patient Number 80 This 36 year old woman was referred for
prenatal screening because of her age. She was entered into
the MRC trial and was allocated chorionic villus sampling.
Preliminary high vaginal swab showed no growth. She
was A Rhesus Positive. At sampling, ultrasonography revealed
a single fetus with a gestational age of 11 weeks. There
was a large cervical fibroid, 5x6 cms, distorting the
endocervical canal. Transabdominal chorionic villus
sampling was performed and 20 milligrams of villi were
obtained on one aspiration.
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The fetal karyotype was 46,XX.
She had a normal delivery at 40 weeks + 3 days gestation
of a live female, 2.7 kilograms in weight. There were no
neonatal complications.
Patient Number 87 This 36 year old woman who had had a
previous Down's fetus terminated at twenty weeks gestation,
was referred by her Obstetrician for chorionic villus sampling.
She had had one other normal pregnancy and delivery.
Preliminary high vaginal swab showed no growth. She
was O Rhesus Positive. At sampling, ultrasonography revealed
a fundal and anteriorly placed placenta. A single fetus
with a gestational age of 10 weeks was seen. The uterus
was anteflexed and the placental site could not be reached
by the transcervical route. One attempt was made. Trans¬
abdominal chorionic villus sampling was performed and 10
milligrams of villi were obtained.
The fetal karyotype was 46,XY.
She had a spontaneous delivery at 39 weeks + 3 days
gestation of a live male, 3.8 kilograms in weight. There
were no neonatal complications.
Patient Number 93 This 37 year old woman was referred by
her General Practitioner for prenatal diagnosis because of
age. She entered the MRC trial and was allocated chorionic
villus sampling.
Preliminary high vaginal swab was negative. She was
A Rhesus Negative. At sampling a single fetus, with a
gestational age equivalent to 10 weeks, was seen. The
placental site was anterior. Transcervical chorionic villus
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sampling proved impossible because her endocervical canal
was narrow and rigid, and the anteriorly placed placenta
could not be reached. Transabdominal chorionic villus
sampling was performed and 35 milligrams of villi were
obtained following two aspirations.
The fetal karyotype was 46,XX.
A Kleihauer test performed after the procedure showed
no fetal cells. 250 IU of Anti-D were given after the
procedure.
She had a spontaneous delivery at 41 weeks gestation
of a live female, 3.5 kilograms in weight. There were no
neonatal complications.
Patient Number 98 This 23 year old woman was referred by
the Regional Clinical Genetics Service. She had had one
pregnancy resulting in a boy suffering from Cystic Fibrosis.
The family were fully informative with DNA cystic fibrosis
gene probes.
Preliminary high vaginal swab was negative. She was
0 Rhesus Positive. At sampling, ultrasonography showed
a single fetus, gestational age 10-11 weeks. Placental
site was posterior and fundal. The mainly fundal placental
site could not be entered satisfactorily via the trans¬
cervical route. Transabdominal chorionic villus sampling
was performed and approximately 30 milligrams of villi
were obtained. Metronidazole in the standard dose was
given for 7 days.
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The results of the DNA probing revealed that the fetus
was neither a carrier nor affected with Cystic Fibrosis.
Cytogenetic analysis of 32 metaphases showed 24 cells with
46 chromosomes (46,XY) and 8 cells with 47 chromosomes
(47,XY,+21) indicating chromosomal mosaicism.
After counselling by the referring Clinical Geneticists,
the patient opted for a termination of pregnancy and this
was performed at 13 weeks gestation. Chromosomal mosaicism
will be discussed in section 8.6 B.
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8.4 TRANSCERVICAL CHORIONIC VILLUS SAMPLING
Ninety three patients had transcervical chorionic villus
sampling performed using the method described in chapter 6.
In three of these patients, insufficient villi were
obtained for diagnostic use and all 3 subsequently had an
amniocentesis (patients 5, 57 and 74).
Ninety patients had successful transcervical chorionic
villus sampling and the villus weights are recorded in Table 36.
A) Failed Transcervical Chorionic Villus Sampling
Patient Number 5 A 41 year old woman who had had 3 normal
children, was referred for chorionic villus sampling by her
Obstetrician because of her age.
Preliminary high vaginal swab was negative. Blood group
was B Rhesus Positive. At sampling, a single fetus with a
gestational age of 10 weeks was seen. Placental site was
fundal. The cannula was inserted in an anterior direction
twice and a posterior direction once but no villi could be
obtained. After counselling, she chose amniocentesis rather
than repeat chorionic villus sampling.
The patient had a normal delivery of a live male,
3.71 kilograms in weight, at term. There were no neonatal
problems.
Patient Number 57 A 26 year old woman who had given birth
to a child with Trisomy 21, was referred by the Clinical
Genetics Service, for chorionic villus sampling.
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Preliminary high vaginal swab was negative. Blood
group was 0 Rhesus Positive. At sampling, a single fetus
equivalent to 10 weeks gestation was seen. The placental
site was posterior and fundal. The uterus was retroverted
and fixed. The placental site could not be reached by the
transcervical route and transabdominal chorionic villus
sampling was thought to be impossible without breaching the
amniotic cavity. She was seen one week later, at 11 weeks
gestation, but the position had not altered and an amniocentesis
was recommended. This procedure was carried out at 17 weeks
and the fetal karyotype was normal.
She had a normal delivery at 40 weeks gestation of a
live female, 3.58 kilograms in weight. No neonatal problems
were encountered.
Patient Number 74 A 39 year old woman was allocated
chorionic villus sampling after entering the MRC randomised
trial.
At sampling a single fetus, equivalent to 11 weeks
gestation, was seen. Placental site was posterior. Two
aspirations were attempted. There was poor visualisation of
the cannula due to her obesity. Brisk bleeding of about
20 millilitres occurred at the second aspiration. The
procedure was stopped. No villi were obtained.
Her bleeding continued off and on for a further ten
days and she was admitted to hospital. Her pregnancy
continued and she had an uneventful amniocentesis at
17 weeks gestation.
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She had a spontaneous rupture of membranes at thirty-
four weeks gestation and delivered a live male, 2.42 kilograms
in weight. There were no neonatal problems.
B) Comment
Patient number 5 may have benefitted from a trans¬
abdominal approach initially rather than a transcervical
and I believe, in those cases with fundal placentae this
should, and now is, the desired approach.
Patient number 57, with a retroverted uterus and a
postero-fundal placenta, is an example of a patient in whom
chorionic villus sampling in the first trimester is not
possible. Second trimester villus sampling may well be
easier in such cases.
Despite a heavy loss of blood, the pregnancy was not
compromised in patient number 74. Whether her chorionic
villus sampling or amniocentesis was responsible for her
premature rupture of membranes is difficult to say. There
was no antenatal or post natal evidence of infection, as a
cause for ruptured membranes in her case.
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8.5 INDICATIONS FOR CHORIONIC VILLUS SAMPLING
A) Maternal Age
The general policy of the West Midlands Regional
Cytogenetics Service is to offer prenatal testing for
chromosomal abnormalities to women aged 36 years and over at
the start of their pregnancies (from October 1987, this
changed to 35 years and over). The risk factors for Down's
Syndrome quoted to such women is shown in Table 37 and is
derived from data from the European Collaborative Study of
Amniocentesis 1984 (Ferguson-Smith 1984).
All patients wishing chorionic villus sampling where
the risk was maternal age entered the Medical Research
Council trial into chorionic villus sampling and amniocentesis,
and after due counselling were randomised to receive either
chorionic villus sampling or amniocentesis.
A total of 42 patients were assigned to chorionic villus
sampling. The ages of the referred patients are shown in
Table 38. Three had transabdominal chorionic villus sampling
(section 8.3). Two patients had unsuccessful transcervical
chorionic villus sampling performed (section 8.4 A). The
remaining 37 patients had successful transcervical procedures.
Table 39 shows the karyotype results.
The outcome of the 42 patients who had successful or
unsuccessful chorionic villus sampling is shown in Table 40.




Age Risk of Down's Syndrome
25 1 in 1,500
30 1 in 800
35 1 in 350
36 1 in 300
37 1 in 200
38 1 in 170
39 1 in 140
40 1 in 100
45 1 in 30
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TABLE 38












MATERNAL AGE: SUCCESSFUL CVS WITH KARYOTYPES
Karyotype Number
46,XX 14




* These cases are discussed in section 8.6 B.
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TABLE 40
OUTCOME OF PREGNANCY IN 42 PATIENTS HAVING CHORIONIC VILLUS
SAMPLING FOR MATERNAL AGE
Number
Delivered live baby > 37 weeks gestation 32
Delivered live baby < 37 weeks gestation 4
Stillbirth 1
Spontaneous abortion 3
Termination of pregnancy 2
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Stillbirth Patient Number 72 This 38 year old woman had
transcervical chorionic villus sampling at 11 weeks gestation.
Preliminary high vaginal swab showed no growth. She was
Rhesus Positive. The placental site was posterior. Twenty
five milligrams of villi were obtained on one aspiration.
The fetal karyotype was 46,XY.
There were no ante natal problems until thirty three
weeks gestation when she was admitted with severe pre-eclampsia
complicated by disseminated intra vascular coagulation and
renal failure. On admission to the labour ward, the fetus
was found to be dead.
Post mortem of the fetus and placenta was performed.
The male fetus weighed 1.93 kilograms (between 10th and 50th
centile for gestational age and sex). There were no external
or internal congenital malformations. The histology of the
placenta showed acute ischaemic changes and massive
perivillous fibrin deposition. The umbilical cord and
membranes were normal.
The cause of fetal death was due to acute intrauterine
hypoxia secondary to her pre-eclampsia.
B) Previous Chromosomal Abnormality
Twenty six patients who had had a fetus or child with a
previous chromosomal abnormality were referred for chorionic
villus sampling. Table 41 details the previous abnormalities.
One patient had unsuccessful chorionic villus sampling
(patient 57, section 8.4 A).
The karyotypes diagnosed by chorionic villus sampling
of the remaining 25 is shown in Table 42.
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TABLE 41





























* Discussed in section 8.6 B.
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Discussion
Twenty six of the 100 diagnostic procedures were
performed in patients with previous chromosomally abnormal
fetuses or children.
Prior chromosomal abnormality was the indication for
chorionic villus sampling in 8.4% of a Dutch series of
500 patients (Leschot et a_l 1987), 4 . 6% of a 1000 diagnostic
chorionic villus sampling patients from California (Hogge et
1986) and 3.6% of 109 chorionic villus sampling patients
reported from Chicago by Elias et ad 1986 . In a further 63
patients who have had diagnostic chorionic villus sampling
in our unit in Birmingham, a quarter were for a previous
chromosomal abnormality, continuing the pattern of the
previous 100 patients.
Although in the twenty six patients there was one fetal
loss (patient 27, section 8.8), it may be that in diagnostic
series in which previous aneuploidy forms a significant
proportion of the total, spontaneous miscarriage may be more
common.
Series such as ours may then be at risk of showing an
excess number of miscarriages in comparison with other series
in which prior chromosomal abnormality forms a small
proportion of patients having chorionic villus sampling.
Such factors make comparisons of spontaneous fetal losses
between centres offering chorionic villus sampling, difficult
(Simpson et ad 1986) .
Two patients (39 and 100) had mosaicism and this will
be discussed in detail in section 8.6 B.
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C) Chorionic Villus Sampling For Fetal Sexing
Fourteen chorionic villus sampling procedures for fetal
sexing were carried out, where the indication was a family
history of an X-linked condition.
One patient (8 and 28) had chorionic villus sampling
carried out in successive pregnancies.
All patients were referred from the Regional Clinical
Genetics Service.
Indications
(i) Family History of Duchenne Muscular Dystrophy
Table 43 details the outcome of 10 procedures for this
indication. One patient (who had 2 chorionic villus sampling
procedures) will be used to illustrate the problems with
chorionic villus sampling in patients with this condition.
Ten procedures were performed in nine patients.
Patient Number 8 and 28 A 23 year old woman who had two
brothers who both died from Duchenne Muscular Dystrophy was
referred for chorionic villus sampling. In her first pregnancy,
she had an amniocentesis showing a female karyotype and
subsequent normal delivery. In this pregnancy, she had
chorionic villus sampling between 9 and 10 weeks gestation
by dates and ultrasound assessment.
High vaginal bacteriology swab was negative. Blood
group was 0 Rhesus Positive. The placental site was
posterior.




CHORIONIC VILLUS SAMPLING FOR FETAL SEXING IN CASES WITH
A FAMILY HISTORY OF DUCHENNE MUSCULAR DYSTROPHY
Patient Gestation Villus Karyotype Outcome
number (weeks) weights (birth details,
(mgs) gestation, weight)
8 9 + 50 46,XY T.O.P.
& 28 11 30 46,XY T.O.P.
23 9+ 40 46,XX Live female, 40+weeks
3.97 kgs.
25 11 30 46,XY T.O.P.
29 10 5 46,XX Live female, 41 weeks
3.67 kgs.
32 10+ 30 46,XX Live female, 42 weeks
3.82 kgs.
50 9+ 40 46,XX Live female, 39 weeks
2.82 kgs.
64 10 30 46,XX Live female, 39 weeks
2.3 kgs.
78 10+ 60 46,XX Live female, 41 weeks
3.9 kgs.
81 10+ 40 46,XY T.O.P.
T.O.P. Termination of pregnancy
kgs Kilograms
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The fetal karyotype was 46,XY.
She had a termination of pregnancy performed at llh
weeks gestation.
Six months later, she presented in her third pregnancy.
At sampling, a single fetus, crown rump length 4.6 cms,
eguivalent to 11 weeks gestation was seen.
High vaginal bacteriology swab was negative. Placental
site was anterior.
Thirty milligrams of villi were obtained on one
aspiration.
The fetal karyotype was 46,XY.
She underwent termination of pregnancy at 13 weeks
gestation.
She presented in her fourth pregnancy for chorionic
villus sampling. By her last menstrual period, she should
have been eight weeks gestation, but on ultrasound scan,
two sacs were seen with no embryo in either. She subsequently
underwent evacuation of the uterus at her local hospital.
Discussion
At the time these patients had chorionic villus sampling
for fetal sexing (1986 and 1987), accurately pinpointing
affected male fetuses using DNA analysis was not possible.
In the illustrative case, the affected brothers were both
dead and therefore DNA analysis of them was impossible. This,
therefore, left fetal sexing as the only option, even though
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normal males may be terminated. A succession of pregnancies
in which males are diagnosed, as in this case, often leads to
much despair and eventually voluntary infertility on behalf
of the couple concerned.
Until such time that specific DNA probes that avoid
recombination at the Duchenne Muscular Dystrophy locus are
available, accurate prenatal diagnosis will be difficult.
In those families without informative relatives, accurate
diagnosis of affected males will be difficult, although
linkage analysis may be possible (Forrest et aJL 1987).
(ii) Family History of Becker Muscular Dystrophy
Patient Number 88 This patient, who had a living brother
with Becker Muscular Dystrophy, was referred for chorionic
villus sampling. Prior to becoming pregnant, she had sought
advice from the Clinical Genetics Department about her chances
of being a carrier for this condition and whether prenatal
diagnosis was possible. Her brother had been shown on DNA
studies (Dr Kay Davies, Oxford), to have a deletion of his
Becker gene. At the time of referral, this DNA probe had
only been in use for a few weeks.
DNA results on the patient suggested that the patient
was not a carrier and her overall risk was put at 1 in 60,
with a 1 in 120 chance of having an affected son (Dr S
Bundey, Clinical Genetics Department, Birmingham Maternity
Hospital). Nevertheless the couple were keen on prenatal
diagnosis, even at such low risk.
High vaginal bacteriology swab was negative. Blood
group was 0 Rhesus Positive. At sampling, a single fetus,
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crown rump length 3.9 cms was seen, equivalent to 10+ weeks
gestation. Placental site was posterior.
Thirty milligrams of villi were obtained on one
aspiration, sufficient for karyotype analysis and DNA
analysis .
The fetal karyotype was 46,XX and therefore further
investigation was not required.
She had a spontaneous delivery at 40 weeks gestation
of a live female, 3.64 kilograms in weight. There were no
neonatal complications.
(iii) Family History of Opitz (BBB) Syndrome
Patient Number 22 is detailed in section 8.3.
(iv) Family History of Fragile X Syndrome
Patient Number 47 This 25 year old woman had one male
child who was mentally retarded and hyperactive. He had
been diagnosed as having the Fragile X Syndrome. When this
case presented, the most reliable method of prenatal diagnosis
was by the cytogenetic analysis of the fetal lymphocytes
obtained by fetal blood sampling (Webb et ad 1987) .
In this case, the chorionic villus sampling diagnosis
of a male karyotype would be followed by later fetal blood
sampling.
Preliminary high vaginal swab yielded some yeasts.
Canestan pessaries, one at night for three consecutive nights,
were prescribed before sampling. Blood group was 0 Rhesus
Positive. At sampling, ultrasonography revealed a single
152 .
fetus, crown rump length 3.5 cms, equivalent to 10 weeks
gestation. Placental site was posterior.
Sixty milligrams of villi were obtained on one
aspiration.
The fetal karyotype was 46,XX.
She had an elective Caesarean Section at 40 weeks
gestation. A live female, 3.64 kilograms in weight, was
delivered. There were no neonatal problems.
(v) Family History of XY Gonadal Dysgenesis
Patient Number 99 This 21 year old woman had an extensive
family history of XY Gonadal Dysgenesis, which is inherited
in an X-linked manner. Her mother had an affected female
child (i.e. one in which a female phenotype was apparent
but with an XY karyotype and dysgenetic gonads).
Patient number 99 had already had a phenotypica1ly
normal male child. She was counselled and referred via the
Regional Clinical Genetics Service with the understanding
that if chorionic villus sampling diagnosed an XY karyotype,
then high resolution ultrasound or fetoscopy would then be
necessary to confirm the presence of male genitalia.
Preliminary high vaginal swab was negative. Blood group
was A Rhesus Positive. At sampling, a single fetus, crown
rump length 3.5 cms was seen, equivalent to 10 weeks
gestation. Placental site was anterior.
Forty milligrams of villi were obtained on two
aspirations.
The fetal karyotype was 46,XY.
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At 18+ weeks gestation, she had ultrasonography
performed and male genitalia were seen.
She had a normal delivery of a live, anatomically normal,
male at 41 weeks and 4 days gestation. Birth weight was
3.8 kilograms. There were no neonatal complications.
D) Fetal Karyotyping Because of a Familial Translocation
Patient Number 41 A 32 year old woman, whose husband had a
balanced translocation 46,XYt(4;15)(q25;q26) was referred for
chorionic villus sampling. They had had one male child who
died and was found to have the unbalanced form of his father's
condition.
Preliminary high vaginal swab showed no significant growth.
Blood group was 0 Rhesus Positive. At sampling, a single
fetus with a gestational age of 9-10 weeks was seen. The
placental site was anterior. Two aspirations produced
25 milligrams of villi.
The karyotype result was 46,XY,-15,+der,t(4;15)(q25;
q2 6)pat.
Termination of pregnancy was performed at 12 weeks
gestation and the products of conception sent to the
laboratory for chromosomal analysis. The result was 46,XY,-15,
+der(15) ,t(4;15) (q25;q26)pat. and confirmed the chorionic
villus sampling result.
Patient Number 49 A 35 year old woman, a known carrier of
the 14; 21 translocation was referred by the Clinical Genetics
Service for chorionic villus sampling. Her karyotype was
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45,XX,t(14q2lq). She had had one termination of pregnancy
for social reasons, one healthy chromosomally normal female
and a girl affected with Down's Syndrome. She had been
given a risk of 1:7 of any future pregnancy being affected
with Down's Syndrome (Dr M Hulten, Consultant Clinical
Cytogeneticist).
Preliminary high vaginal swab showed no significant
growth. Blood group was A Rhesus Positive. A single fetus,
gestational age 10 weeks, was seen. Placental site was
posterior. Between 10 and 20 milligrams of villi were
obtained on two aspirations.
In 13 of 15 cells analysed, the karyotype was 46,XY,-14,
+t(14q21q), consistent with a clinical picture of Down's
Syndrome.
Termination of pregnancy was performed at 12 weeks
gestation and products of conception sent to the laboratory
for analysis. Culture of these products showed a karyotype
46,XY,-14,+t(14q21q), thus confirming the result of the
chorionic villus sampling procedure.
This patient was subsequently sterilised at her own
request.
Patient Number 90 A 28 year old woman, whose husband had a
Robertsonian translocation was referred by her General
Practitioner. She had had an amniocentesis in her one
previous pregnancy and had a normal delivery of a live female
with a normal karyotype.
Preliminary high vaginal swab showed no growth. Blood
group was 0 Rhesus Positive. At sampling, two sacs were
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seen, one empty and one with a fetus with a crown rump length
of 4-6 cms equivalent to 11-12 weeks gestation. The
placental site was posterior and 15 milligrams of villi were
obtained in one aspiration.
The fetal karyotype was 46,XY.
At 37 weeks gestation, she had a spontaneous delivery
of a live male, 3.57 kilograms in weight. There were no
neonatal complications.
E) Biochemical Analysis
Three patients, whose cases will be described individually
were referred for chorionic villus sampling by the Regional
Clinical Genetics Department and the Biochemistry Department,
Birmingham Children's Hospital.
Patient Number 6 This 31 year old woman had given birth
to a child in 1985, who died in the early neonatal period
with methylmalonic aciduria. This is an autosomal recessive
condition with a one in four recurrence risk. The condition
is not amenable to dietary treatment after birth.
She became pregnant in 1986, and was seen by a
Consultant Clinical Geneticist. The enzyme defect in the
family had been shown to be a Methylmalony1-CoA mutase
deficiency. This enzyme acts in the formation of protein
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By incorporating radiolabelled carbon (Carbon 14) as
propionate into the sample, its detection in synthesised
protein would mean there is no block to its incorporation
in the pathway outlined above and therefore its presence
indicates an unaffected individual.
The couple were referred for chorionic villus sampling,
and understood that if the biochemical result from the
chorionic villus sample was normal, an amniocentesis, for
confirmation would be necessary. The arrangements for
biochemical analysis of the villi were that the sample would
be sent to Dr W Kleijer's laboratory in Rotterdam, who had
previously monitored four pregnancies with this condition
using chorionic villus samples (3 unaffected and one affected
which was terminated).
A high vaginal swab taken prior to sampling grew
Candida species and a Beta haemolytic streptococcus, treated
successfully with Canestan pessaries and oral Erythromycin.
Blood group was A Rhesus Negative. At sampling, a single
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fetus, crown rump length 3.1 cms was seen. Placental site
was posterior.
Ten milligrams of villi were obtained on two aspirations.
A Kleihauer test was done after the procedure and this was
negative. Anti-D, 250 IU was given. There were no immediate
problems.
14
RESULT:- The Rotterdam laboratory showed that C
propionate incorporation was substantial in the villus
sample consistent with a fetus unaffected with methylmalonic
aciduria.
The couple were told this result with the caveat that
amniocentesis for confirmation would be necessary.














Normal Range (±2 SD) 0-0.8
Affected values more than 13.
- 0.58
0.08, 0.15, not detected.
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CULTURED AMNIOTIC FLUID CELLS
moles propionate/mole phenylanine incorporated x 10
-3
Fetus 7.9, 4.7, 7.1
(Triplicate of separate cultures)
Controls (6) 98.0 (± 26.8 (Mean ± SD))
(71.1 - 136 (Range))
CULTURED SKIN FIBROBLASTS
Previous affected child 6 . 7
Normal Control 88 . 2
These results showed that the fetus was affected with
methylmalonic aciduria.
After counselling from the Consultant Clinical Geneticist,
the patient underwent extra amniotic Prostaglandin termination
of pregnancy at 20+ weeks gestation.
Cultured fibroblasts from the terminated fetus were
consistent with the amniocentesis result, demonstrating a
fetus affected with methylmalonic aciduria.
Patient Number 19 A 17 year old girl presented to the
Clinical Genetics Department, approximately eight weeks
pregnant. Her sister (patient number 75) had had a son
who had died with Menkes' Disease.
Menkes' Disease is a syndrome of congenital copper
disturbance characterised by increased copper accumulation
in multiple cell types in the body. Affected male fetuses
accumulate excessive amounts of copper in placental tissue
and this accumulation is said to be useful in prenatal
diagnosis, with the principal site of copper accumulation
being the trophoblast (Horn 1981).
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In 1985, an affected male fetus had been diagnosed
using chorionic villus sampling in the tenth week of
pregnancy and the diagnosis verified after abortion
(Tjinnesen 19 8 5) .
Unfortunately carrier detection tests for Menkes'
Disease had not been carried out on patient number 19
as this pregnancy was unexpected.
Her sister, a known Menkes' Disease carrier (patient
number 75) had had chorionic villus sampling successfully
performed in 1985, and patient number 19 wished to avail
herself of this test. She was given a risk of a male fetus
being affected by Menkes' Disease of 1 in 4 by the Clinical
Geneticists, and because experience worldwide with this test
was small a confirmatory amniocentesis was recommended.
Prior to sampling, an endocervical bacteriology swab
had shown no significant growth. Blood group was 0 Rhesus
Positive. At sampling, a single fetus, crown rump length
4.7 cms was seen, equivalent to 11 weeks gestation. Placental
site was anterior.
Two aspirations were made using a Portex catheter
(Portex Limited), as described in chapter 3, but with the
suction device, as described in chapter 6 attached. The
choice of this catheter will be explained in describing patient
number 75. Ten milligrams of villi were obtained and the villi
were cleaned and packed in a copper free solution to
Dr TjAnnesen's laboratory in Denmark. A further sample,
approximately 30 milligrams was obtained using an aluminium
cannula for fetal karyotyping.






0.66 parts per million
1.0 parts per million
0.4-1.1 parts per million
These results suggested a fetus unaffected with
Menkes' Disease.
She had amniocentesis performed at 16 weeks gestation.
RESULT
CULTURED AMNIOTIC FLUID CELLS
64 -1 -1 , .
ng Cu. 20hr mg protein
Patient Culture 1 16.1
Culture 2 12.7
Control (1) run in 11.2
Menkes'(Fibroblasts)(1) parallel 97.5
Reference Ranges
Menkes' amniotic fluid cells (12)
Control amniotic fluid cells (20)
Mean 95% limits of range
53.7 37.0-95.0
17.7 7.8-27.8
These results were not consistent with a diagnosis of
Menkes' Disease.
These results agreed with the villus results. At 38+
weeks gestation, she had a normal delivery of a live male,
2.87 kilograms in weight.
Serum copper and caeruloplasmin from the child confirmed
that it was unaffected with Menkes' Disease.
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Patient Number 75 This 24 year old woman, the elder sister
of patient number 19, had had two children. A healthy boy
born in 1982 and a boy in 1983 who died at the age of 7 months
from Menkes' Disease. She was referred via the Biochemistry
Department, Birmingham Children's Hospital for prenatal
diagnosis.
She had chorionic villus sampling performed in our unit
in 1985 and 1987 in her third and fourth pregnancies.
Third Pregnancy - 1985
Preliminary high vaginal swab was negative. Blood group
was 0 Rhesus Positive. At sampling, a single fetus, 9 weeks
gestation was seen. The placental site was posterior.
Transcervical chorionic villus sampling was performed using
the method described in chapter 3. Sufficient villi for
biochemical analysis was obtained. Two samples from women
undergoing first trimester termination of pregnancy were
sent as controls. These had been taken using a malleable




Patient Aluminium Cannula 3 .50
Control 1 MSS Cannula 2 .42
Control 2 MSS Cannula 2 .85
Normal Controls (n=12) 0.24-1.02
Diagnostic sample (n=9) 0 .20-0.80
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These results from Dr T T(/>nnesen, John F Kennedy
Institute, Glostrup, Denmark, were difficult to interpret.
Their previous experience had all been with villus samples
obtained using the Portex cannula (Portex Limited) which had
a plastic cannula (though inner aluminium obturator which
was removed after placement but prior to villus sampling).
The patient underwent amniocentesis at 16 weeks gestation.













Menkes' amniotic fluid cells (n=12) 37.0-95.0
Control amniotic fluid cells (n=90) 7.8-27.8
These results were consistent with a fetus unaffected with
Menkes' Disease.
The discrepancy in the copper uptake values in the
controls and in the patient's villus samples which had been
taken with metal cannulae was possibly due to copper
contamination from the cannulae themselves. However, an
enguiry to the manufacturers of the metal cannulae (Rocket
of London Limited), had shown that the aluminium cannula
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was made from commercial grade material which was 96% pure
aluminium and the remainder was made up of various elements,
including copper, to produce the various quantities of the
alloy. The stainless steel tubing was allowed a maximum of
0.1% of copper and ideally should contain none at all.
Heavier concentrations of copper were found in the brass
Luer fittings, which contained 2/3 copper. The jointing
metal was called silver solder, and this had a 30% copper
content. The jointing material on the aluminium cannula was
either cyanoacrylate or epoxy resin. Therefore the
manufacturers would expect very small quantities of the hub
to be exposed to the incoming sample. The male Luer fitting
on the collecting syringe would take up most of the available
space, and the tubing was deeply counter bored into the
fitting.
At forty weeks gestation, the patient had a normal
delivery of a live female, 4.1 kilograms in weight.
Samples of the placenta and umbilical cord were sent
to Denmark for analysis. Measurement of placental copper
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was normal but measurement of radioactive copper uptake (Cu )
in the umbilical cord showed the child to be a carrier.
Fourth Pregnancy - 1987
In her fourth pregnancy, the patient requested chorionic
villus sampling. Because of the problems with interpretation
of the copper content on villus samples taken with the
aluminium cannula in her third pregnancy, it was decided to
use the Portex Cannula for sampling.
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Transcervical chorionic villus sampling was performed
at 9-10 weeks gestation. A single fetus was seen and the
placental site was posterior. High vaginal swab was
negative. Forty milligrams of villi were obtained.
The fetal karyotype was 46,XY.
BIOCHEMICAL RESULT










The conclusions from Dr Tjinnesen's laboratory was that
the male fetus was affected with Menkes' Disease. Previous
experience (4 affected fetuses) had shown fetuses with these
ranges of results to be affected.
After counselling with the patient's Obstetrician and
the Clinical Genetics Department, she had a termination of
pregnancy performed at twelve weeks gestation. Samples of
fetal tissue were sent to the Danish laboratory for con¬












Control (in parallel) 22 . 3
Menkes' Syndrome (in parallel) 77.8
Normal Male Controls (20) 95% range 9.0-33.3
Menkes' Syndrome (26) 95% range 46.6-99.9
These results were consistent with a diagnosis of
Menkes' Disease and confirmed the result from the chorionic
villus sample.
DISCUSSION
The discrepancy between the result obtained from the
chorionic villus sample and the amniotic fluid sample was of
great concern to all those involved in the management of case
number 6. The specific enzyme Methylmalony1-CoA mutase
could not be used as a direct measurement in the chorionic
villus sample in this particular family as the specific
defect was in a co-enzyme essential to the function of the
mutase and the mutase levels themselves were normal in the
child that had died. One of the reasons put forward by the
Dutch laboratory for the incorrect diagnosis was maternal
cell contamination of the chorionic villus sample. This is
possible, but the sample was sent 'cleaned' to the laboratory
and a further washing and cleaning of the sample took place
in the Dutch laboratory. Another possibility is that the
piece of villi sent was 'dead', and therefore no enzyme
activity was present, but this would be likely to give such
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abnormal results that suspicions would be raised (G Gray,
Principal Biochemist, Birmingham Children's Hospital-
Personal Communication).
Despite much discussion between the Dutch laboratory
and the laboratory in Birmingham, no satisfactory explanation
was given as to why the villus result was incorrect. This
led to chorionic villus sampling not being recommended to
this couple in their next pregnancy and the patient had an
amniocentesis, with subsequent normal results.
In the two cases of Menkes' Disease, it was discovered
that copper contamination from the sampling instruments
could lead to confusing results (though not a true false
positive). The laboratory concerned (in Denmark) now make
it a policy that chorionic villi sent to them for copper
measurements be taken using an all plastic cannula
(TizSnnesen et a_l 1987) .
These cases illustrate the difficulty of using chorionic
villi for biochemical analysis in cases of certain inborn
errors of metabolism. Proper diagnostic assessment should
include biochemical analysis of the fibroblasts of an index
case and confirmation of any negative result from a villus
sample by amniotic fluid analysis.
167.
F) DNA Analysis from Chorionic Villi
Twelve patients were referred for chorionic villus
sampling, for DNA analysis.
Indications
(i) Haemophilia A - Patient Number 18
A 28 year old woman was referred for chorionic villus
sampling by her Obstetrician. The patient herself had read
about chorionic villus sampling and DNA analysis of
haemophilia, and contacted her Obstetrician with a view to
early prenatal diagnosis. In her first pregnancy an
amniocentesis had shown a female fetus.
Her male first cousin was affected with Haemophilia A
and DNA analysis had been performed by the Haematologists
on his mother, and patient number 18's mother.
The family tree had been investigated using a probe for
the intragenic polymorphism in the factor VIII gene which
gives bands of 1.1 and/or 0.8 kilobases (Kb) with the
enzyme Bell (Dr I Peake, University of Wales).










The patient herself had had her factor VIII levels
measured (66%) and von Willebrand factor antigen (120%),
strongly suggesting she was a carrier. She was heterozygous
1.1/0.8 for the Bell polymorphism and so this could be used
for analysis.
A high vaginal bacteriology swab showed no growth.
Blood group was 0 Rhesus Positive. At sampling, a single
fetus with a crown rump length of 4.3 cms was seen.
Placental site was posterior.
Thirty milligrams of villi were obtained on one
aspiration. The sample was sent to Dr I R Peake, Principal
Scientist, Department of Haematology, University of Wales
College of Medicine.
RESULTS
Using a Y specific probe, the fetus was shown to be
male. Using the Bell polymorphism probe, a 1.1 Kb band
alone was seen. Both tests were repeated and gave identical
results.
This result strongly suggested that the fetus had
inherited Haemophilia A, as the 1.1 band was the allele in
her affected cousin.
Termination of pregnancy was carried out at 13 weeks
gestation.
Patient Number 48 This 26 year old woman, a carrier for
Haemophilia A, was referred via a Consultant Haematologist
in another Health Authority. They had tried to organise
chorionic villus sampling within their own Health Authority
area but had been unsuccessful.
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The patient had one brother who was affected with
Haemophilia A and one sister who was a carrier. She had had
no previous pregnancies. The Director of Derby Haemophilia
Centre (who had referred the patient) had applied DNA probes
to the family and the patient was fully informative for
Haemophilia A.
She was 10 weeks gestation at referral. A high vaginal
bacteriology swab was taken and showed no significant growth.
On ultrasound, a single fetus, crown rump length 3.8 cms,
was seen. Placental site was posterior.
A total of 30 milligrams of villi was obtained and split,
such that 20 milligrams were sent to Dr I Peake, Cardiff and
10 milligrams retained for karyotype analysis.
The fetal karyotype was 46,XX.
The patient had an uneventful pregnancy with a
spontaneous vertex delivery of a live female, 3.34 kilograms
in weight, at 39+ weeks gestation.
(ii) ^-Thalassaemia
/i-Thalassaemia is caused by at least 30 different
mutations (Orkin et al_ 1983). Most cases of /3-thalassaemia
have to be diagnosed by linked DNA polymorphisms or by
hybridization with oligonucleotide probes. Because most of
the polymorphic restriction sites in the y3-globin gene
cluster occur on both normal and ^3-tha lassaemic chromosomes,
it is necessary to establish linkage between a particular
restriction fragment length polymorphism (RFLP) and the
mutant gene by a family study. This can be done easily if
the couple have a normal or homozygous ^-thalassaemic child
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from which blood can be obtained. Both cases of /3-thalassaemia
described (patients 42 and 52), had such family studies done
(Dr J Old's Laboratory, Oxford). To establish linkage in
each case most laboratories study 7 RFLPs, and the presence
or absence of each polymorphic site along the chromosomes
can be worked out for each family. Examples of this are
seen in the description of each case.
Patient Number 42 A 29 year old Pakistani woman was
referred for chorionic villus sampling by the Haematology
Department, Birmingham Children's Hospital. She had had
three previous pregnancies. She had a 9 year old son
affected with /3-thalassaemia major. She had fetoscopy and
fetal blood sampling in her next two pregnancies (1981 and
1983). Both children were found to be unaffected using
DNA analysis (Dr J Old, National Haemoglobinopathy
Reference Service, Oxford).
High vaginal bacteriology swab was negative. Blood
group was 0 Rhesus Positive. At sampling, a single fetus
equivalent in size to 11 weeks gestation was seen. The
placental site was anterior.
Fifty milligrams of villi were obtained on one
aspiration.
The fetal karyotype was 46,XY.
DNA RESULTS (Dr J Old, Oxford)
Yield of DNA - 190 pg. Three different DNA polymorphisms




(1) Hind IIIla —/+-
(2) Hind Il/e -/+
(3) Hind II /(f)fi —/ + +



















Unfortunately because the DNA was partially degraded
when it reached Dr Old's laboratory in Oxford, he could
not tell if the fetus had ^-thalassaemia trait or not.
The probe necessary for that Hind III/PRK 29 produces large
bands (18 kilobases) and these had repeatedly not shown up
in the fetal sample.
At 39 weeks gestation, the patient had a normal delivery
of a live male, 3.25 kilograms in weight. There were no
neonatal problems.
Patient Number 52 A 27 year old Cypriot woman, whose
husband was also a Cypriot, was referred for chorionic villus
sampling by her Obstetrician. Both she and her husband were
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^3-thalassaemia carriers. She was an insulin dependent
diabetic. She had one normal child, (i.e. with normal
values of Haemoglobin A^), born in 1983.
In 1984, she had transcervical chorionic villus sampling
performed in London and subsequently spontaneously aborted.
Because of this and the fact that she was a diabetic, I felt
that the preferred route of sampling was transabdominal.
High vaginal bacteriology swab was negative. Blood
group was A Rhesus Positive. At sampling, the placental site
was posterior. A single fetus, crown rump length 3.0 cms,
equivalent to 9 to 10 weeks gestation was seen.
Transabdominal sampling was performed but only 5
milligrams of villi, insufficient for DNA analysis was
obtained. Under antibiotic cover (Metronidazole 200 mgs
and Ampicillin 500 mgs), a single transcervical aspiration
was performed and a further 40 milligrams of villi were
aspirated.
The fetal karyotype was 46,XX.
DNA RESULTS (Dr J Old, Oxford)

















This showed the fetus to be homozygous for ^-thalassaemia.
The patient underwent a termination of pregnancy at 13 weeks
gestation.
(iii) Sickle Cell Anaemia
single base substitution of A (Adenosine) to T (Thymidine)
in Codon 6 of the fi globin gene. This base substitution
abolishes 3 different restriction enzyme recognition sites
in the normal ft gene. The third of these, called Mst II
generates large fragments that can blot easily and hybridize
normally, and this enzyme is now used by most centres for
the prenatal diagnosis of sickle cell anaemia (Old 1986).
Patient Number 91 A 36 year old woman, who had two living
children with sickle cell disease was referred by the
Haematology Department, Birmingham Children's Hospital.
High vaginal swab was negative. Blood group was 0
Rhesus Positive. At sampling, a single fetus with a crown
g
The ft gene responsible for sickle cell anaemia is a
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rump length of 4.1 cms was seen, equivalent to 11 weeks
gestation. Placental site was posterior and right lateral.
Fifteen milligrams of villi were obtained on two
aspirations.
The fetal karyotype was 46,XX.
DNA RESULTS (Dr J Old, Oxford)
Yield of DNA - 41 pig.
Ms t 11//J : -/-
The fetus was homozygous for sickle cell disease.
The patient underwent termination of pregnancy at
13 weeks gestation.
(iv) Cystic Fibrosis
Although Cystic Fibrosis is a disease in which the
precise biochemical defects have not been discovered, it
can now be detected in many couples at risk using DNA probes
linked to the cystic fibrosis locus. The cystic fibrosis
gene is now known to be situated on the long arm of
chromosome number 7 (at 7q21-q31)[Dean et a_l 1985; Bartels
et al 1986] .
For diagnostic purposes, probe pJ3.11, met H and met D
are used. The two markers met and pJ3.11 are so close to
the cystic fibrosis gene that recombination is likely to be
less than 1% (Personal communication quoted by Brock 1987).
On the basis of known allele frequencies, 80% of
couples should be fully informative for one of these
markers and the remainder to be half informative (Brock 1987).
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However, when DNA is not obtainable from an affected child,
then prenatal diagnosis using these markers is not possible.
The genotypes of a family may be fully informative when
the cystic fibrosis bearing chromosomes in both parents can
be identified. The ideal should be that their genotypes
are known before pregnancy.
In the 7 patients referred for chorionic villus sampling,
5 were fully informative and 2 were partially informative
on the basis of DNA analysis using probes met H, met D and
pJ3.11. All patients undergoing sampling had the sample
split so that karyotype analysis was also performed as well
as DNA analysis. All DNA analysis was carried out by
Dr M Super, Clinical Genetics Unit, Royal Manchester
Children's Hospital.
Table 44 shows the outcome of the 7 patients.
Patient Number 45 In this case, the family were partially
informative using probe met H. The family were fully
informative using probe 79a but Dr Super's laboratory were
unhappy about using this probe because there would be a
16% error rate for a diagnosis of Cystic Fibrosis using it.
DNA analysis of the fetus showed it to be a homozygote
for the met H probe but this meant that the fetus had a 1 in
2 chance of being affected (see Pedigree). After counselling
from the Consultant Clinical Geneticist, the patient chose
a termination of pregnancy.
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TABLE 44
CHORIONIC VILLUS SAMPLING IN FAMILIES WITH CYSTIC FIBROSIS
Patient Genotype known Gestation Prediction










45 met H, met D
pJ3.11 (partially
informative)
10 1:2 risk of
CF. 46,XX
T.O.P.










*71 met H, partially 11+ Carrier




95 met H, met D, 10+ Carrier




:98 met H, met D,
pJ3.11





* Further discussed in section 8.8.
** Described in sections 8.3 and 8.6 B(iii).
CF Cystic Fibrosis
kg Kilogram
T.O.P. Termination of pregnancy
Pedigree - patient 45
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Patient Number 95 This patient had transcervical chorionic
villus sampling performed at 10+ weeks gestation. Twenty
milligrams of villi were obtained. The family had been
investigated in Edinburgh using probes met H, met D and
pJ3.11 and were fully informative. However, due to
technical difficulties at the Edinburgh laboratory no result
was obtained.
After further counselling by the referring Clinical
Genetics Consultant, she underwent transabdominal chorionic
villus sampling at 13+ weeks gestation. The placental site
was posterior.
Twenty milligrams of villi were obtained on one aspiration.
The villi were sent to Dr Super's laboratory in Manchester.
The fetus was found to be a carrier. The fetal
karyotype was 46,XY.
She had a spontaneous delivery at 37 weeks gestation
of a live male, 2.85 kilograms in weight. There were no
neonatal problems.
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8.6 COMPLICATIONS OF DIAGNOSTIC CHORIONIC VILLUS SAMPLING
A) Infant Death
Patient number 56 delivered at 27 weeks gestation and
the baby died at 2 months of age.
She was a 40 year old woman of Indian origin who
wished prenatal diagnosis because of her age. She was
randomised to receive chorionic villus sampling after entering
the MRC trial. She had had two previous pregnancies
resulting in normal deliveries of live female children.
A preliminary high vaginal swab had shown a heavy growth
of Candida species and she received treatment with Canestan
pessaries prior to chorionic villus sampling. Blood group
was B Rhesus Negative. At sampling, a single fetus equivalent
to 11 to 12 weeks gestation was seen. The placental site
was posterior.
Twenty five milligrams of villi were obtained with one
transcervical aspiration.
The fetal karyotype was 46,XY.
Immediately following the chorionic villus sampling a
Kleihauer estimation was performed showing a feto-maternal
transfusion of approximately 5 millilitres. A total of
500 IU of Anti-D was therefore given.
Her pregnancy progressed uneventfully but she went
into premature labour at approximately 27 weeks gestation.
She was delivered of a live male, 990 grams in weight (50th
centile for gestational age and sex). At birth he was
ventilated for only a short time.
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Clinical progress was satisfactory until 4 to 5 days
before death (at the age of 2 months), when he was treated
with antibiotics for a Group A Beta Haemolytic Streptococcus
which had grown in material from his ear. He rapidly
deteriorated after this and three days before his death
appeared to have aspirated a large guantity of milk. Despite
being put on the ventilator, he could not maintain his
partial pressure of oxygen even on 100% oxygen concentrations
and he died at 2 months of age.
A final histological report from the Pathologist was
as follows:
Cause of death
(1) Bilateral haemorrhagic bronchopneumonia
(2) Aspergillus infection of both lungs
(3) Hypoxic necrosis of the brain.
There was no histological examination of the placenta.
COMMENT
While the chorionic villus sampling procedure was
straightforward and atraumatic, a significant fetomaternal
haemorrhage occurred and it is interesting to note the
presence of a retro-placental clot at delivery. Presumably
premature labour occurred because of an antepartum
haemorrhage but whether a procedure performed fourteen weeks
previously can be implicated in the acute episode is
difficult to say without proper histology of the placenta.
This patient and patient number 35 both had significant
fetomaternal haemorrhages, as estimated by a Kleihauer test
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and both had complications of pregnancy (premature labour
at 26 weeks and spontaneous abortion at 13 weeks respectively).
It is possible that the presence of placental clot
could lead to a localised inflammatory process leading to
necrosis, haemorrhage and further placental separation
(D I Rushton, Consultant Pathologist, Birmingham Maternity
Hospital - Personal Communication).
B) Mosaicism
In the 100 diagnostic cases, 95 had karyotype analysis
performed. There was one true mosaic (patient number 79).
All karyotype analysis was on direct chromosome preparations
as outlined in chapter 7.
Table 45 summarises the cases of Mosaicism.
Patient Number 79 A 36 year old woman had transcervical
chorionic villus sampling performed at 11 weeks gestation.
The indication was maternal age. The placental site was
anterior and 40 milligrams of villi were aspirated.
Twenty five metaphase spreads were analysed. Seven
spreads showed a 46,XX karyotype and 18 spreads a 45,X
karyotype.
Amniocentesis was performed and 30 metaphase spreads
analysed in culture. Twelve spreads showed 46,XX and
18 showed 45,X.
After termination of pregnancy, culture of fetal skin




PATIENT INDICATION CVS AMNIOCENTESIS PREGNANCY
NUMBER RESULT OUTCOME
10 Age 46XY/47XY,+15 [40/4] 46,XY Term male
39 Prev.Downs 46XY/47XY,+3 [61/2] 46,XY Term male
53 Age 46XY/47XY,+3 [36/4] - Term male
79 Age 46XX/45X [7/18] 46XX/45X [12/18] T.O.P.
98 C.F. 46XY/47XY,+21 [24/8] - T.O.P.
46XY fetal culture
100 Prev.Downs 46XY/47XY,+3 [28/2] - Term male
T.O.P. Termination of Pregnancy
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There were five cases of mosaicism apparently confined
to the placenta.
(i) Trisomy 15
Patient Number 10 A 38 year old woman had chorionic villus
sampling for maternal age reasons. Transcervical chorionic
villus sampling was performed at 11 weeks gestation. The
placental site was anterior, 20 milligrams of villi were
aspirated.
A total of 44 metaphase spreads were analysed. Forty
spreads showed a 46,XY karyotype and 4 spreads a 47,XY,+15
karyotype.
Although the significance of this was in doubt, after
counselling from the Clinical Genetics Consultant, the
patient underwent amniocentesis at 16 weeks gestation.
The karyotype of all cultured cells was 46,XY. At 40 weeks
gestation, she had a normal delivery of a live male,
3.84 kilograms in weight. There were no neonatal problems.
(ii) Trisomy 3
Three patients numbered 39, 53 and 100 had Trisomy 3.
Patient Number 39 A 27 year old woman, who had had a
previous Down's baby, underwent transcervical chorionic
villus sampling between 10 and 11 weeks gestation. The
placental position was posterior and 30 milligrams of villi
were aspirated.
A total of 63 metaphase spreads were examined. Sixty-
one showed a 46,XY karyotype and 2 showed a 47,XY,+3 karyotype.
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Amniocentesis was performed at 17 weeks gestation.
All cultured cells showed a 46,XY karyotype. At term,
she had a normal delivery of a live male, 3.85 kilograms
in weight. There were no neonatal problems.
Patient Number 53 A 41 year old woman underwent trans¬
cervical chorionic villus sampling between 10 and 11 weeks
gestation. The placental site was posterior and 10
milligrams of villi were obtained.
A total of 40 metaphase spreads were examined. Thirty-
six showed a 46,XY karyotype and 4 showed a 47,XY,+3
karyotype.
Her referring Obstetrician did not recommend to her
that any further investigation be carried out as he did not
regard the result as being indicative of fetal abnormality.
She had a normal delivery at term of a live male, 3.09
kilograms in weight. There were no neonatal problems.
Patient Number 100 A 38 year old woman had transcervical
chorionic villus sampling performed at 11 weeks gestation.
She had had a previous child with Down's Syndrome. The
placental site was posterior and thirty milligrams of villi
were aspirated. Thirty metaphase spreads were examined.
Twenty eight had a 46,XY karyotype and 2 had a 47,XY,+3
karyotype.
No further antenatal tests were recommended.
She was delivered by Caesarean Section at 40 weeks
gestation, of a normal male, 4.3 kilograms in weight. There
were no neonatal problems.
(iii) Trisomy 21
Patient Number 98 This 23 year old woman, with a child with
Cystic Fibrosis, had transabdominal chorionic villus sampling
performed between 10 and 11 weeks gestation. The placental
site was fundal and posterior. A total of 30 milligrams of
villi was obtained (DNA analysis - see section 8.3).
Karyotype analysis was also performed. A total of
32 metaphase spreads were examined. Twenty four had a
46,XY karyotype and 8 had a 47,XY, + 21 karyotype.
The Clinical Geneticist could not give the patient and
her husband complete reassurance that the fetus did not
have Mosaic Trisomy 21 in other cell lines. As the couple
had undergone prenatal diagnosis to minimise the risk of
having a child with an abnormality, they felt that they
would prefer the earlier option of termination of pregnancy,
rather than wait for later confirmatory tests.
She underwent termination of pregnancy at twelve weeks
gestation. Culture of the fetal skin (6 cells analysed and
95 cells counted) showed a 46,XY karyotype with no evidence
of the abnormal Trisomy 21 cell line.
(iv) Discussion
Mosaicism is defined as the presence within one
individual of two or more cell lines exhibiting different
karyotypes. Pseudo-mosaicism, in which the two cell lines
are present in the karyotype of the cultured tissue but not
within the fetus, has been described in amniotic fluid cell
cultures. It is thought to be due to either a cultural
artifact occurring in vitro or contamination of the amniotic
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fluid sample by chorionic or maternal tissues.
In a review of mosaicism in amniotic fluid culture,
Gosden (1983) reported that 80% of autosomal mosaicism was
due to pseudo-mosaicism but that pseudo-mosaicism only
accounted for 40% of sex chromosome mosaicism.
The mosaicism occurring in the five cases in which it
was not confirmed in the fetus could not be due to cultural
artifact as all karyotype were direct preparations. In a
series of 46 third trimester placentae that were karyotyped,
two were found to have mosaicism confined to the placenta
(Kalousek et a_l 1983). These authors and others (Gosden 1983 ;
Cheung et a_l 1987), have speculated that mosaicism may occur
more frequently in the chorion and have quoted the findings
of a study of the mouse blastocyst in which only three out of
its 64 cells formed the embryo, the remaining cells forming
the trophoblast (49 cells) and amnion, yolk sac and allantois
(12 cells) (Markert et a_l 1978) . The fact that not all the
cells of the extraembryonic tissues are of fetal origin could
mean that non-disjunction during early embryogenesis might
produce mosaicism within the placenta or fetus but not
necessarily in both.
In a review of 6125 karyotype analyses from diagnostic
chorionic villus samples, Mikkelsen reported 45 mosaics of
which 37 could not be confirmed in fetal cells, amniotic
fluid culture or at birth (Mikkelsen 1987).
The mosaicism involving the sex chromosome in case
number 79, warranted further tests which confirmed the
results from the villus sample. In mosaicism involving the
sex chromosomes detected in villus samples, follow up
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investigations should be recommended. Similarly, in the
case of mosaicism for Trisomy 21 (case number 98), which is
known to account for 1-2% of individuals with Down's Syndrome
(Gosden 1983), further tests would be indicated assuming the
parents did not wish immediate termination of pregnancy. In
cases in which mosaicism involves outcomes of no known
clinical significance e.g. Trisomy 3 or 15, further prenatal
tests should not be recommended especially, as in this series,
the number of metaphases exhibiting the trisomy was far
outnumbered by the number with a normal karyotype.
The implications for counselling patients who wish
chorionic villus sampling for karyotype analysis is that a
discrepancy between the karyotype of the placenta and that
of the fetus may occur in up to 5% of cases. Where this
discrepancy involves a sex chromosome, chromosomes 21, 18,
13 or 8, then further prenatal diagnostic tests should be
performed. Where, as is more likely, it involves chromosomes
of no known clinical significance e.g. Trisomy 3 or 15,
then further prenatal tests are not warranted.
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8.7 OUTCOME OF 100 DIAGNOSTIC CHORIONIC VILLUS SAMPLING
PROCEDURES
The outcome of the one hundred diagnostic chorionic
villus sampling procedures is shown in figure 20.
A) Premature Delivery
Delivery before thirty seven weeks gestation occurred
in six patients. Three of these have already been described
Patient 56, section 8.6 A; Patient 72, section 8.5 A and
Patient 74, section 8.4 A.
Of the remaining three patients delivery occurred in
the following circumstances.
Patient Number 32 This patient had transcervical chorionic
villus sampling performed at 10% weeks gestation for fetal
sexing. The sex was female.
At 36 weeks gestation, labour was induced because of
suspected intrauterine growth retardation. A vaginal delivery
of a live female, 2.07 kilograms in weight (below the 10th
centile for gestational age and sex), occurred. There were
no neonatal complications.
Patient Number 40 This 42 year old woman had transcervical
chorionic villus sampling because of maternal age. A normal
karyotype was obtained.
She went into spontaneous labour at 35 weeks gestation
and had a vaginal delivery of a live male, 2.66 kilograms in
weight (between the 50th and 90th centile for gestational age
and sex). There were no neonatal complications.
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FIGURE 20
OUTCOME OF 100 DIAGNOSTIC CHORIONIC VILLUS SAMPLING PROCEDURES
T.O.P. Termination of pregnancy
AMNIO Amniocentesis
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Patient Number 66 This 39 year old woman had transcervical
chorionic villus sampling at 10 weeks gestation for maternal
age reasons. The placental site was posterior and low.
She had an emergency Caesarean Section at 35 weeks and
3 days gestation because of vaginal bleeding. Placenta praevia
was diagnosed. A live male, 2.15 kilograms in weight was
delivered (between 10th and 50th centile for gestational age
and sex).
B) Birth Weights of the 80 Delivered Patients
The birth weights of delivered patients were recorded
and compared to standard charts, of weight related to
gestational age and sex, devised by Gairdner and Pearson
1971 (revised 1985).
The mean birth weight of the eighty patients was
3.38 kilograms, S.D. 0.61.
Table 46 shows the birth weights by centiles and in
four cases the birth weight was below the 10th centile.
There were no neonatal complications in any of these cases.
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TABLE 46
BIRTH WEIGHT CENTILES (after Gairdner and Pearson 1971)
Birth Weight Centiles Number of Babies
< 10th 4
> 10th < 50th 31





Spontaneous abortion in this series is defined as the
death and expulsion of the fetus before 28 weeks gestation.
Five patients had a spontaneous abortion following chorionic
villus sampling. They are detailed individually and Table 47
summarises the cases.
Patient Number 27 A 39 year old woman was referred for
chorionic villus sampling by her Obstetrician. She had two
normal deliveries and one extra amniotic Prostaglandin
termination of pregnancy at 22 weeks gestation after
amniocentesis had shown a fetus with Down's Syndrome.
High vaginal bacteriology swab showed no growth. Blood
group was 0 Rhesus Positive. At sampling, a single fetus,
11 weeks gestation in size, was seen. The placental position
was posterior and lateral.
Two transcervical aspirations produced less than
10 milligrams of villi and a third about 10 milligrams of
villi. There was some slight bleeding after the procedure.
The fetal karyotype was 46,XY.
Vaginal bleeding persisted and she was admitted to
hospital at 12 weeks gestation. The day prior to her
spontaneous abortion a live fetus was seen on ultrasound
scan. She aborted at 13 weeks gestation.
Histology of abortus The Pathologist's report was as
follows:-
An intact amniotic sac containing a fresh externally
normal male fetus crown rump length 7.4 cms, crown heel
9.8 cms, foot 1.1 cms weighing 24.9 grams. The cord
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TABLE 47


















27 11 3 Posterior 20 13-14
35 11 3 Post/Fundal 5 13
59 11 1 Posterior 15 15
71 11+ 1 Posterior 30 23
73 11 1 Anterior 15 13-14
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measures 11 cms. The placenta is fragmented and received
with much fresh blood clot. No lesion attributable to
chorionic villus biopsy is identified though this does not
exclude the possibility that the procedure was a
contributory factor leading to abortion.
Histology
The cord, membranes and placenta are normal.
Patient Number 35 A 36 year old woman, who had had one
previous normal child by her first marriage, wished prenatal
diagnosis because of maternal age. She was randomised to
receive chorionic villus sampling.
High vaginal swab showed no growth. Blood group was
0 Rhesus Negative. At sampling, a single fetus equivalent
in size to 10 weeks gestation was seen. The uterus was
retroverted. The placental site was fundally placed and
transcervical chorionic villus sampling was difficult
because of this.
Three attempts were made and 5 milligrams of villi were
obtained from the edge of the placenta.
The fetal karyotype was 46,XY.
Some slight vaginal bleeding was noted at the time of
the procedure. As she was Rhesus Negative, a Kleihauer test
was done after the procedure and this showed an approximate
25 millilitres estimate of fetomaternal transfusion. A
total of 2500 IU of Anti-D was therefore required.
Twelve days later, she aborted spontaneously.
Unfortunately, no histological examination of the placenta
or fetus was carried out at her local hospital.
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Patient Number 59 A 42 year old woman was referred for
chorionic villus sampling by her Obstetrician. She had had
one normal delivery of a healthy female and two first
trimester miscarriages at 7 and 9-10 weeks gestation
respectively. She entered the MRC trial and was randomised
to receive chorionic villus sampling.
Preliminary high vaginal swab was negative. Blood group
was 0 Rhesus Positive. An ultrasound scan at her local
hospital had suggested twins, but at sampling a single fetus
only was seen with a size equivalent to 11 weeks gestation.
There was no evidence of a second sac. Placental site was
posterior.
One attempt at transcervical chorionic villus sampling
produced 15 milligrams of villi. There were no difficulties.
The fetal karyotype was 46,XX.
She was admitted to her local hospital at 14+ weeks
gestation with a threatened miscarriage. Ultrasound scan
was performed which showed a live fetus. She miscarried
two days later at 15 weeks gestation. Histology was carried
out at her local hospital and the Pathologist's report
was as follows:-
Specimen: Fetus and placenta
Apparently normal male fetus 9.5 cms crown to rump
length. Head circumference 9.5 cms and weighing 41 grams.
It is not macerated and the organs show no major abnormality.
Separate placenta and membranes weighing 63 grams. There is
a velamentous insertion of the cord. The placenta appears
normal.
Histology
Placenta and fetal organs showed no histologic abnormality.
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Patient Number 71 A 32 year old woman was referred for
chorionic villus sampling by the Clinical Genetics Department.
She had one normal son and one son affected with Cystic
Fibrosis.
The DNA probes on the affected son and the parents
showed that they were partially informative using probe met D
and uninformative using probe met H (see section 8.5 for
description of DNA probes on Cystic Fibrosis).
Preliminary high vaginal swab showed a growth of
Gardnerella Vaginalis and pre, per and post procedure
treatment with metronidazole, 200 milligrams three times a
day, was instituted. Blood group was A Rhesus Positive.
At sampling, a single fetus with a gestational age equivalent
to 11 weeks was seen. Placental site was posterior. Thirty
milligrams of villi were obtained on one transcervical
aspiration.
The fetal karyotype was 46,XY. DNA studies showed the
fetus to have the genotype "1,1" meaning that it was either
a carrier or unaffected.
She was admitted to her local hospital at 23 weeks
gestation and miscarried.
Histology of abortus
A male fetus measuring 165 mms crown rump length
appearing to be normal on external examination. Dissection
shows no obvious abnormality of the internal organs. The
placenta weighs 168 grams and it is entire with little
infarction. Sections show normal placental tissue only.
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Patient Number 73 A 39 year old woman, who had had two
normal deliveries and one miscarriage at 8 weeks gestation,
was randomised to chorionic villus sampling after entering
the MRC trial.
High vaginal swab showed no growth. Blood group was
0 Rhesus Positive. At sampling, a single fetus was seen
with a gestational age of 10-11 weeks. The placental site
was anterior.
Fifteen milligrams of villi were obtained with one
transcervical aspiration.
The fetal karyotype was 46,XX.
She had an ultrasound scan performed two weeks later
showing a live fetus of appropriate size. She miscarried
the following day at home. Only a fetus was available for
histology report. The Pathologist's report was as follows:-
Histology of fetus
Macroscopic; Small fetus showing early maceration.
Crown rump length 8 cms, crown-heel 10.8 cms, foot length
1.1 cms, 6 cms of cord on body. The external genitalia are
ambiguous but no external abnormality evident. The internal
genitalia are female, and no definite internal abnormality
is seen.
Histology
The measurements correspond by size to a gestation of
13 weeks. Sections of the fetal organs show no diagnostic
abnormality. The umbilical cord contains three vessels.
Diagnosis




The spontaneous abortion rate in this diagnostic series
of 100 patients is 5.7%. This is calculated after subtraction
of the 15 patients who had termination of pregnancy performed.
This rate compares to the 1% loss rate following amniocentesis
(Tabor et aA 1986) .
The abortion rate in this series of patients can be
compared to the varying rates of spontaneous abortion,
following transcervical chorionic villus sampling, of 1.2%
to 8.5% guoted by those centres reporting on series in
excess of 100 patients (Jackson 1987).
The critical guestion, what is the inherent miscarriage
rate due to chorionic villus sampling, is difficult to
answer. Within this series of patients, four of the five
who miscarried had histological examination of the abortus
performed and none had abnormalities that the Pathologist
attributed to the sampling procedure. My own belief is
that patients 27 and 35, who had persistent bleeding after
the procedure, and evidence of considerable fetomaternal
haemorrhage, aborted as a direct result of the procedure.
Both cases required three passages of the cannula to acquire
a diagnostic sample. The other 3 patients, all of whom had
had previous spontaneous abortions and in whom there was no
histological evidence of a direct link to chorionic villus
sampling, may fall into the category of unrelated
spontaneous abortion. The effect of a history of previous
spontaneous abortion on the risk of subsequent abortion will
be examined in the next chapter.
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The role of infection in spontaneous abortion is well
known. Transcervical chorionic villus sampling introduces
the possibility of infecting the sterile intrauterine
environment. In all 100 diagnostic cases, care was taken to
exclude or treat infection prior to sampling as well as
administer a prophylactic antibiotic to decrease the risk of
abortion due to anaerobic or similar organisms, known to be
difficult to routinely culture. In order to establish whether
or not infection, and thus inflammation, of the abortus is
related to chorionic villus sampling, it would be necessary
to demonstrate that the proportion of cases that abort,
showing signs of infection, is significantly greater than
that in a control population of spontaneously aborting women
of similar gestation. More background data relating to the
true incidence of spontaneous abortion in ultrasonically
intact pregnancies followed from the first trimester to
28 weeks gestation is needed. This will be examined in the
next chapter.
Proper histological examination of abortions following
chorionic villus sampling is mandatory. Pathological
findings of decidual inflammation and chorioamnionitis in
abortuses following chorionic villus sampling should be
interpreted with caution. Chorioamnionitis is found in at
least a quarter of fresh spontaneous abortions (Rushton 1984)
and thus, in individual cases, it cannot be assumed that the
chorionic villus sampling was responsible for its presence.
The true excess miscarriage rate attributable to
chorionic villus sampling can only be accurately assessed
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in large scale randomised trials (Chalmers 1987) in which
matched patients are randomly assigned to receive either
amniocentesis or chorionic villus sampling at an early stage
in their pregnancy and followed through to delivery.
The virtues of one method of chorionic villus sampling
compared with another can again only be assessed in a
similar fashion. According to Jackson (Jackson 1987), in
those centres reporting their experience of transabdominal
procedures, the fetal loss rate varies from 1.7% to 4.8%
(compared with 1.2% to 8.5% for the larger series of
transcervical procedures).
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AN INVESTIGATION OF SPONTANEOUS ABORTION IN ULTRASONICALLY
VIABLE PREGNANCIES
9 . 1 INTRODUCTION
In the diagnostic series of 100 pregnancies in which
chorionic villus sampling was performed (Chapter 8), there
were five spontaneous abortions. This represents a
spontaneous abortion rate of 5.8% for the diagnostic series
(5 of 85 pregnancies intended to continue). Without knowing
the background rate of naturally occurring spontaneous abortion,
the excess abortion rate due to chorionic villus sampling is
difficult to quantify.
Estimations of the naturally occurring spontaneous abortion
rate are imprecise and there is little reliable actuarial data
available for determining the chances of any given pregnancy
ending in spontaneous abortion. Such information would be
invaluable in counselling women prior to procedures such as
chorionic villus sampling. Biochemical, clinical and recently
ultrasound studies have all produced different estimations
of fetal loss.
In biochemical studies in which pregnancy is diagnosed
by a positive beta-human chorionic gonadotrophin (beta HCG)
assay, the diagnosis of pregnancy and the subsequently derived
determination of fetal loss is dependent on the characteristics
of the assay used. This was demonstrated by the studies of
Miller et al_ 1980 , Edmonds et a_l 1982 and Whittaker et a^ 1983 ,
in which the spontaneous abortion rates in biochemically
diagnosed pregnancies that were subsequently recognised
clinically were 13.7%, 11.7% and 12.9% respectively. The
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unrecognised loss rates (spontaneous abortion rates in so-
called occult pregnancies) were 32.9%, 56.8% and 7.6%
respectively. The disparity in the latter figures reflects
the different assays and criteria used for the biochemical
diagnosis of pregnancy in each study.
Clinical studies, both retrospective and prospective,
are flawed by the difficulty in determining the significance
of a delayed or missed period, which could represent either
an early spontaneous abortion or an irregularity of the
menstrual cycle. Most retrospective studies (reviewed by
Simpson and Mills 1986) consistently report clinical
spontaneous abortion rates of between 12 and 15%. Recent
retrospective data (Wilson et a_l 1986 ; Christiens et a_l 1986 ;
Gustavii 1984 b and Gilmore et a_l 1985) examined those pregnancies
in which fetal viability was assessed ultrasonically. These
studies all showed a much lower spontaneous abortion rate
than that quoted from clinically recognised abortion studies.
However, all the recent ultrasound studies were retrospective
and in one widely quoted study (Wilson et a^ 1986) , the indication
for first trimester ultrasound assessment was vaginal bleeding
in up to 27% of their patient population. Therefore their
data may not be relevant to estimations of background risks
in populations undergoing chorionic villus sampling.
A prospective series of patients was therefore examined
in whom there was ultrasound evidence of fetal viability prior
to twelve weeks gestation and who were followed up to at
least twenty eight weeks gestation.
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9 . 2 PATIENTS AND METHODS
All patients presenting to the Birmingham Maternity
Hospital for their first ante natal visit have an ultrasound
scan performed. Five hundred patients were selected in whom
a live fetus was seen, with a gestational age as assessed by
crown rump length measurements of less than twelve weeks
gestation. The names, Medical Record number and parity of
these patients were recorded. Patients who presented at their
first visit in excess of twelve weeks were excluded, as were
multiple gestations and those in which there was no or
doubtful evidence of fetal viability. The Medical Records of
the five hundred patients were then examined after the
five-hundredth recruited patient was at least 28 weeks gestation.
9.3 RESULTS
Table 48 shows the age group distribution of the 500
patients. There were ten spontaneous abortions (2%) and four
induced abortions. Of these four, one was performed on mental
health grounds, one for a complication of Rhesus disease at
23 weeks gestation and two were for neural tube defects at
20 and 22 weeks gestation.
Table 49 lists the gestation at booking, as assessed by
ultrasound, and the gestation at abortion in the 10 patients
who spontaneously aborted. One patient had spontaneous rupture
of the membranes at 19 weeks gestation. The fetus was 46,XX
at autopsy and structurally normal. One patient developed
hydramnios at 21 weeks gestation and premature labour. The
fetus was anatomically normal at autopsy. Two patients had
vaginal bleeding and aborted at 14 weeks gestation.
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TABLE 48
AGE DISTRIBUTION OF PATIENTS
Spontaneous
abortion Totals
Age group (yr) N Q.*o N %
0-15 0 0.0 1 0 . 2
16-20 1 3 . 3 30 6.0
21-25 2 1.6 122 24.4
26-30 6 3 .1 195 39 . 0
31-35 1 0 . 9 116 23 . 2
36-40 0 0 . 0 32 6 . 4





GESTATIONAL AGE AT BOOKING SCAN AND ABORTION











* Hydramnios and premature labour. No fetal abnormality
at autopsy.
** Spontaneous rupture of membranes at 19 weeks. No fetal
abnormality at autopsy.
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Table 50 shows the abortion rate in those patients with
no history of abortion and in those with a history of one or
more spontaneous abortions. Ten patients with a history of
therapeutic induced abortion were excluded. There was a
highly significant difference in the spontaneous abortion rate,
from 0.6% in patients with no history of spontaneous abortion
to 5.5% in those with such a history (p<.005).
Table 51 shows the number of patients with a viable fetus
at specific gestational ages and the number of subsequent
spontaneous abortions. There were six spontaneous abortions
out of 157 women in the group below ten weeks gestation (3.8%) ,
compared with four out of 343 women (1.2%) at greater than ten
weeks gestation at the initial booking scan. These differences
are significant (X2 = 3.87; ,05>p>.001).
9.4 DISCUSSION
The 'naturally occurring' spontaneous abortion rate in
this group of prospectively studied women was 2%. Recent
ultrasound studies have shown similar figures (Wilson et a_l
1986 ; Christiens et aA 1984 and Gilmore et a_l 1985). If this
is taken as the minimum figure then for the diagnostic series
of chorionic villus sampling procedures, the excess abortion
rate is at most 3.5%.
This study has also shown that other factors must be
considered when estimating the risk of spontaneous abortion.
One factor is a history of spontaneous abortion which in this
study increased tenfold the risk of aborting compared with the
group of women who had never had a spontaneous abortion. In
the diagnostic series, two of the five cases who aborted following
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TABLE 50
HISTORY OF PREVIOUS SPONTANEOUS ABORTIONS
Spontaneous
abortions
No. of patients N %
No history 339 2 0.6
One or more abortions 147 8 5.5*
* X2 = 11.9; p<.005
TABLE 51
GESTATIONAL AGE AT BOOKING SCAN









chorionic villus sampling had had previous first trimester
spontaneous abortions.
Spontaneous abortion is less likely as pregnancy
progresses, Gustavii 1984 b. This study confirms this trend.
Spontaneous abortion at less than ten weeks gestation was up
to three times greater than that at over ten weeks gestation.
This has implications for the timing of chorionic villus
sampling and, in my opinion, chorionic villus sampling should
not be offered below ten weeks gestation, as the chance of
aborting is higher. Comparisons of loss rates from different
centres due to chorionic villus sampling should take into
account the gestation at which sampling occurred.
Previous reports (Gustavii 1984 b; Gilmore et a_l 1985)
have already demonstrated the adverse effects of maternal age on
spontaneous abortion rates but the number of patients in this
prospective study aged 35 or older was too small to draw any
conclusions about this factor. Four of the five spontaneous
abortion cases from the diagnostic series of chorionic villus
sampling procedures were over 35 years of age.
A large prospective study of spontaneous abortion in
women in the older age group would be needed to estimate a
background rate of spontaneous abortion, but because of the
small number of older women in any one centre, a multi-centre









































































































Generation of orders: 1 AL Aluminium
2 MSS Malleable Stainless Steel
3 P Portex
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Direct Prep, (result) 46XX/46XY/








The method used is that of Seabriqht (Seabriqht 1971)
1. Aqed slides or slides aqed overniqht at 50°C, are used.
2. Standard Salt Concentrate (SSC) is made from Concentrated
Salt Concentrate (CSC).
3. Unstained slides are put into SSC for half an hour.
4. Slides are next put into 0.9% Saline at room temperature
to cool.
5. Slides are put into 0.6 mis of bactotrypsin in 60 mis
of 0.9% Saline for 1 minute. This step bands the
chromosomes.
6. Slides are washed first in 0.9% Saline.
7. Further wash in Phosphate Buffer Solution (PBS). This
step eliminates crystal formation on the slides.
8. Slides are stained with freshly prepared Leiqhman stain,
in a concentration of 1:5 with PBS. Staininq takes
approximately 5 minutes.
9. Slides are washed in PBS and blotted dry.
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APPENDIX 4
CHORIONIC VILLUS SAMPLING PACK STERILE
No. Description
1 Wool balls sterile
1 Swab gauze 10 cm x 10 cm (5's) sterile
2 Towel dressing folded 16 x 16 in unsterile
2 Linen work drape (202) type
2 Gallipots foil 100 ml unsterile
1 Tray wrap blue 1400 mm x 1000 mm
1 Cusco's speculum
1 Tenaculum
2 Sponge holding forceps
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